US4802475A - Methods and apparatus of applying intra-lesional cryotherapy - Google Patents
Methods and apparatus of applying intra-lesional cryotherapy Download PDFInfo
- Publication number
- US4802475A US4802475A US07/064,619 US6461987A US4802475A US 4802475 A US4802475 A US 4802475A US 6461987 A US6461987 A US 6461987A US 4802475 A US4802475 A US 4802475A
- Authority
- US
- United States
- Prior art keywords
- needle
- skin
- given
- cryogen
- lesion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 62
- 238000000315 cryotherapy Methods 0.000 title claims description 4
- 230000003902 lesion Effects 0.000 claims abstract description 43
- 238000007710 freezing Methods 0.000 claims abstract description 40
- 230000008014 freezing Effects 0.000 claims abstract description 40
- 238000002681 cryosurgery Methods 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 238000003780 insertion Methods 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 6
- 239000004809 Teflon Substances 0.000 claims description 5
- 229920006362 Teflon® Polymers 0.000 claims description 5
- 239000011810 insulating material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000001272 nitrous oxide Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims 1
- 239000012212 insulator Substances 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 31
- 239000007789 gas Substances 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 25
- 238000001356 surgical procedure Methods 0.000 description 13
- 230000006378 damage Effects 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 9
- 239000007921 spray Substances 0.000 description 7
- 230000035515 penetration Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 241000197194 Bulla Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 208000002352 blister Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 206010037649 Pyogenic granuloma Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 238000009116 palliative therapy Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B18/0218—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/27—Cryogenic
Definitions
- This invention relates to a method and apparatus for applying cryotherapy and more particularly to apparatus and methods employing specifically shaped elongated tubular needles inserted through the skin of a patient to destroy lesions by passing a cryogen through the needle.
- Cryogenics are primarily concerned with the development of freezing temperatures within a biological system.
- use of cryogenics in medicine dates back to the ancient Egyptians of 2500 BC as they found that the application of cold soothes sites of trauma and reduces inflammation.
- Cryosurgery is based on withdrawal of heat from a biological system which will lead to freezing of the tissues and transformation of the water from solution into biologically inert ice crystals. In turn this will lead to cessation of circulation in the tissues with intra- and extra-cellular biochemical, anatomical and physiological sequel which will end in tissue anoxemia and ischemic necrosis.
- the critical temperature at which cells die when they are frozen may occur between -2° C. and -4° C. It was found that -50° C. is the optimal temperature for achieving effective cryonecrosis of malignant tumors of the skin.
- cryosurgery The two most commonly used refrigerants in cryosurgery are nitrous oxide (N 2 O) and liquid nitrogen (LN 2 ). The latter is the only coolant effective for malignant tumors as it has a lower boiling point up to -195.6° C.
- Cryosurgery is used for treating benign, premalignant and some cutaneous malignant lesions. In addition, it was found to be useful for palliative therapy of malignant conditions.
- the shape of the cryolesion (produced by application of either technique to the surface) is hemispherical as the ice front advances from the surface downward.
- This hemispherical ice ball cannot be perceived during the freezing procedure but it can be balloted by palpitation, which is adequate for the most superficial lesions, but it is of little value for the common nodular carcinomas of the skin which need measuring of the temperature in depth through thermocouple needles or other apparatus.
- the rate of extension of freezing slows as conditions at the periphery approach equilibrium between heat loss and heat supply by circulation. In general, the depth of freezing may be judged by the lateral spread of frost from the probe and this is used as a guide in treatment. It is just about the radius of the surface area and about half the radius of the ice ball in the cryo-spray technique.
- the choice of technique is based in part on technical consideration but also in part on personal preference.
- the advantage of a probe technique is that it produces a more predictable area freezing, deeper penetration in addition to the possibility of pressure on the probe which increases the depth of penetration through compression of the tissue.
- Cryo-probes may be either applied to the surface of a lesion or inserted into the tissues (especially pointed probes) to produce deep freezing.
- Surface freezing with application of slight pressure is used more commonly than probe insertion as it has the advantages that no wound is caused, little or no bleeding occurs, need for anesthesia is lessened and the danger of dissemination of tumor cells are minimized.
- insertion of the probe into the tissue has its advantage in that it increases efficiency of freezing because of greater contact with the freezing surface.
- probes are employed by application of the probes to the surface of the skin to transmit the cold to deeper tissues. Due to the length of time required, this technique results in damage to the overlying tissue.
- Such probes are available from many concerns such as the Brymill Corporation of Vernon, Conn. 06066.
- the gas circulates inside its lumen.
- the probes contain an inlet conduit and an outlet conduit both of which are associated with a probe tip.
- larger probes which can perform deeper penetration are wide and have diameters in excess of 3 mm.
- these probes are employed together with surgical procedures using scalpels, punch biopsy, electrocautery and so on. The use of the larger probes is limited due to the attendant surgical procedures requiring a large bleeding field and local anesthesia to enable the probe to be inserted at the proper depth.
- the advantage of the spray technique is that the cryogenic agent is used at its coldest possible temperature and the spray can be moved freely about the lesion so that freezing can be extensive and wide rather than deep (as it does not compress tissues).
- the principal problem with the spray is that freezing is difficult to achieve and prolonged use in one area results in healthy tissue destruction. This is in addition to the possibility of gas insuflation of subcutaneous tissues and the possibility of infection with organisms which the gas may contain (as Staphylococcus albus).
- the destruction of a deeper tissue by the commonly used techniques need more destruction of the superficial tissues as the cooling starts from above. This will lead usually to unwanted manifestations and uncommonly to some complications.
- the undesirable clinical manifestations start by wheal formation due to liberation of histamine from degranulated mast cells. This is usually followed by formation of a bulla due to dermal-epidermal separation while with deeper freezing the blister does not develop.
- the bulla may be hemorrhagic and sersanguineous exudate may persist coming out up to 10 days or more. Oedema and crust formation usually follow and complete re-epithelization may not take place (in some lesions) before two months of cryosurgery.
- Zacarian D. made an experiment using ultrasound and hoped for a visual demonstration of the evolving cryolesion. But, during the freezing state, the ultrasound was unable to detect the hemispherical ice formation or depth of the ice front below the skin surface and within the tumor. He stated that further devices should include the ability to visualize and measure the volume of the evolving cryolesion and detect the advancing hemispherical ice front during cryosurgery.
- FIG. 1 is diagrammatic view showing a use of a needle according to this invention and employed with a cyrotherapeutic technique.
- FIG. 2 is a diagrammatic view showing the needle of FIG. 1 being inserted through the skin.
- FIG. 3 is a diagrammatic view showing the needle of FIG. 1 in position.
- FIG. 4A is a diagrammatic view showing the needle coupled to a source of gas to remove or freeze a lesion according to the techniques and methods of this invention.
- FIG. 4B is a diagrammatic view depicting the apparatus of FIG. 4A and showing one technique for determining the depth of freezing.
- FIG. 5 is diagrammatic view depicting a transverse section of the treated area as in FIG. 4B showing the use of thermocouples to determine temperature.
- FIGS. 6-8 are diagrammatic views employing the use of a hook-shaped needle according to this invention.
- FIG. 9 is a diagrammatic view showing the use of the needle in FIGS. 6 and 7 as applied to a gaseous source.
- FIG. 10 is a diagrammatic view of a partially insulated needle showing the use of such a needle to remove a particular lesion adjacent a body orifice.
- FIG. 11 is a diagrammatic view of one particular needle according to this invention.
- FIG. 11B depicts the needle of FIG. 11 used in a cyrotherapeutic procedure according to this invention.
- FIG. 12 is a diagrammatic view of another needle employed according to this invention.
- FIG. 12B depicts the needle of FIG. 12 used in a typical application according to this invention.
- FIG. 13 shows a needle of a different configuration while FIG. 13B shows the needles of FIG. 13 utilized in a cyrosurgical procedure.
- FIGS. 14 and 15 show two different needles of a fish-hook configuration having different gas discharge openings which openings are oriented in different directions.
- FIGS. 14B and 15B show the needles of FIGS. 14 and 15 respectively used in a cyrotherapeutic operation.
- FIGS. 16A to 21A depict various needle configurations employing different portions of insulation.
- FIGS. 16B to 21B depict the needles in FIGS. 16A to 21A used in therapeutic applications.
- FIGS. 22A and 23A depict alternate embodiments of needles employed with this invention.
- FIGS. 22B and 23B depict needles in FIGS. 22A and 23A utilized in therapeutic applications.
- FIGS. 24A and 25A depict alternate embodiments of insulated needles according to this invention.
- FIGS. 24B and 25B show the needles of FIGS. 24A and 25A utilized in surgical procedures.
- FIGS. 26A and 27A depict alternate embodiments of needles employed according to this invention.
- FIGS. 26B and 27B show the needles of FIGS. 26A and 27A utilized in surgical procedures.
- FIG. 28 shows the use of a multiplicity of needles employed during a surgical procedure and according to the methods described in this invention.
- FIG. 1 there is shown a needle 10 which is employed in accordance with this invention. Also shown in FIG. 1 is the hand of a physician who is going to utilize the needle 10 in order to perform a cyro-therapeutic operation as the removal of a lesion from the patient.
- each needle is composed of a shaft 11 and a headpiece 12.
- the needle is a hollow tubular member having a sharpened point 14 which point 14 terminates in an opening.
- the headpiece 12 is the connecting part which connects the hollow shaft to the cyro-surgery apparatus.
- the cyro-surgery apparatus is a source of cyrogen which for example may be liquid nitrogen or nitrous oxide. This source contains the pressurized cyrogen which is inserted into the needle via the headpiece 12.
- the headpiece 12 is of a conventional design and may be implemented in many different ways according to the source of cyrogen to be utilized.
- the headpiece 12 may be a threaded screw member or some other coupling device to enable one to couple the needle and shaft into a source of pressurized gas.
- the headpiece 12 may be integrally formed with the shaft 11 and thus form a complete integral structure.
- the shaft 11 of the needle is formed of a strong and sterilizable material such as stainless steel.
- the shaft 11 may be of any diameter permitting easy effective cooling by the gas which is applied through the internal hollow of the shaft 11.
- the usually used diameters of needle 11 are between 0.5 to 1.0 millimeters. It is of course understood that the diameter employed may vary according to the particular procedure employed.
- the needle 10 has a bend forming an angle which angle may be up to 130°.
- a typical length of the shaft may be greater than 3.5 centimeters while typical lengths employed are between 8 to 16 centimeters to allow the headpiece 12 to be far enough from the surface of the skin to avoid and prevent any danger which may occur from contact with the cold parts of the apparatus or due to leakage.
- This length is also selected to enable the practitioner to obtain a proper field of view while performing the method to be described.
- the shape of the needle may vary according to the particular techniques employed. As seen from FIG. 1, the physician grasps the skin above the affected proceeds to insert the needle from one point so that the needle passes through the skin as shown in FIG. 2 whereby the tip or point 14 passes directly through the area to be treated.
- the angle portion of the needle is then positioned to lie beneath the skin at a predetermined depth based on the formed angle.
- the angle portion of the needle is located directly beneath the surface of the skin at a given depth while the point 14 is positioned within the atmosphere.
- a source 20 containing a cyrogen is coupled to the headpiece 12.
- the gas is passed through the needle thus lowering the temperature as well as the temperature of the surrounding tissue.
- the gas as seen in FIG. 4A is discharged via the point opening 14 into the atmosphere.
- suitable sheets 15 of insulating material such as Teflon, nylon, paper towels or any other suitable material. This material 15 is used to protect the patient's skin from contact with the visible cold parts of the needle.
- an ice cylinder designated by the dashed lines will be formed around the imbedded part of the needle in the deeper tissues.
- the temperature can be lowered by increasing the time of gas passage until a desired temperature is reached.
- the needle shown in FIG. 1 contains a bend and is angulated with the direction of the opening 14 being in the upward direction. It is of course understood that the bend may be located at any point along the shaft as between the junction of the interior third with the posterior third or at the middle of the needle.
- the angle as indicated may be more or less than 130°, but 130° is considered desirable.
- the main objective of the present invention is to provide a specifically shaped needle which needle for example contains a shaped area allowing deep penetration into the skin.
- the needle being of a small diameter and having a sharpened point can then be inserted at any desired depth.
- a source of cyrogen can be accommodated and pass through the needle.
- the needle will allow the gas to be discharged due to the fact that the needle is inserted into the skin and then pushed so that the point end and opening is pushed through the skin.
- the physician utilizes the needle in the simple procedure shown in FIGS. 1-4A and eliminates the necessity of performing any surgical procedures as well as eliminating the need for providing the patient with an anesthetic due to the simple procedures involved.
- FIG. 4B there is shown the apparatus of FIG. 4A wherein the gas is being passed through the hollow of the needle 11.
- the physician can determine the extension of whitish freezing areas as 21 and 22 around the points of contact between the surface and the appropriate portions of the needle. This whitish area represents another indicator for the determination of the extent of freezing.
- thermocouple probes 27 and 26 there is shown two thermocouple probes 27 and 26.
- the thermocouple needles are inserted into the area being treated by the needle 11 and are utilized to measure the temperature of the area to determine proper freezing of the area.
- FIGS. 6-9 there is shown a different needle configuration and a procedure which is accomplished utilizing the needle.
- the needle 31 is curved or of a hook shape configuration.
- the needle 31 again has a hollow shaft having an opening 32 to allow gas inserted into the needle by means of a headpiece 12 (not shown) to be discharged into the atmosphere.
- a headpiece 12 not shown
- FIG. 6 To the right of FIG. 6, there are shown two views showing the surgeon's hands in raising the skin so that the needle can be inserted as shown in FIG. 7 and then, as indicated in FIG. 8, is pushed so that the opening 32 now extends from the skin.
- FIG. 9 shows the same needle 31 accommodating a source of cryogen 36 which is applied to the needle via the headpiece 35. As one can ascertain from FIG. 9, the gas is discharged accordingly. Also shown in FIG. 9 is a clamp 37 which is an insulated clamp and which is held by the physician while directing gas through the needle 31 to enable the physician or an assistant to pull upwardly.
- the dashed line area shows the area of freezing which would be accommodated utilizing the needle depicted in FIG. 9.
- FIG. 10 there is shown still another example of a hook shaped needle 40.
- the needle 40 has a layer 41 of insulating material such as a Teflon disposed on a surface.
- the Teflon layer 41 is disposed along the arcuate section of the needle and along the shaft section leaving a portion 43 unexposed.
- Shown to the left of the needle is a tumor location 50 which essentially is a deep tumor.
- the needle 40 is then inserted into the skin by means of the above-described techniques and the cryogen gas is applied to the hollow of the needle with the aperture 42 allowing the gas to be expelled and sprayed away from the patient.
- FIGS. 11 and 12 depict two different needles 50 and 51 wherein the angle of the bend is less in FIG. 11 than it is in FIG. 12. It is of course understood that both needles can be employed to freeze different types of lesions at different depths. It is also understood that both needles have associated therewith a suitable headpiece for coupling to a source of gas.
- FIG. 11B shows the use of the needle 50 in regard to a surface lesion 60 while FIG. 12B shows the use of the needle 51 in regard to another surface legion 61.
- FIG. 13 shows another needle configuration 62.
- FIG. 13B shows a needle 62 operating in conjunction with a lesion 63. It is shown that needle 62 is arcuate in configuration having less of a curve then for example the needle shown in FIG. 10.
- FIGS. 14 and 15 there is shown two needles 70 and 71 basically each having a straight shaft with the distal end being curved as part of a circle.
- the opening 72 associated with needle 71 is directed towards the inside of the circle while the opening 73 associated with needle 70 is directed away from the circle.
- the direction of gas flow is shown in FIGS. 14 and 15.
- FIGS. 14 and 15 indicate that the openings in regard to the tip of the needle can be oriented in different planes to therefore direct or discharge the gas in different directions depending upon the particular surgery to be performed.
- FIGS. 14B and 15B show the use of the two different types of needles depicted in FIGS. 14 and 15 as being utilized to freeze different types of lesions.
- FIGS. 16A-21A depict a series of needles having different sections thereof insulated to allow the needle to be utilized to selectively freeze lesions of different sizes and different depths.
- FIGS. 16B-21B show the needles employed with different lesions. As one can determine, the needle shown in FIG. 16B has a shaft 80 which is insulated in area 81 and 82 leaving the central portion or angular portion exposed. The needle is used to freeze a lesion 83.
- FIG. 17B shows still another needle configuration having a different angular configuration.
- the needle 84 has areas 85 and 86 which are insulated leaving the angular portion again uninsulated and utilized to remove a lesion 87 shown
- FIG. 20B shows still another needle 88 having an insulated portion 89, a central insulated portion 90 and an end portion 91. It is noted that the portion 90 associated with the angular bend is insulated at the bottom surface and uninsulated at the top surface and is utilized to freeze a lesion such as 92.
- FIG. 21B shows still another needle whereby the angular portion or section is uninsulated at the top surface having insulated section 94 and 95 adjacent to the same and is utilized to remove or freeze a lesion designated by reference numeral 96.
- FIGS. 18A, 19A, 18B and 19B show needles which are of hook shaped configurations having different sections thereof insulated with the needle 100 shown in FIG. 19A having a different direction opening from the needle 102 shown in FIG. 18A.
- FIGS. 18B and 19B show the needles of 18A and 19A employed to remove tumors as 110 and 111 with saving of the surface tissue.
- bent needles having insulation applied around the outside surfaces thereof near the arcuate bends allowing a portion of the needle to be exposed such as portions 115 and 116. It is noted that the difference between the needles in 23A and 22A involve the directional openings as 117 and 118.
- FIGS. 23B and 22B show the needles of FIGS. 22A and 23A being employed to remove tumors 130 and 131 with the direction of gas being discharged through the different orifices in different directions and allowing freezing to occur only in the center.
- FIGS. 24A and 25A show two different needle configurations 120 and 121 having selective areas covered with insulation to allow the bottom portions of the needle to effectuate freezing in FIGS. 24B and 25B. These are used for obliterations of small blood vessels and other superficial linear lesions.
- FIGS. 26A and 27A show again different arcuate shaped needles 122 and 123 having the bottom portions thereof insulated to allow the removal of certain types of tumors as indicated in FIGS. 27B and 26B with sparing of deeper tissues.
- FIG. 28 shows the use of multiple needles 125 and 126 to freeze a given lesion. It is thus obvious that one can utilize multiple needles to effectuate freezing of various different types of tissue at the same time or afterwards.
- certain surface portions of the needle can be insulated by the use of suitable insulating materials such as Teflon which permits selective freezing of upper or lower tissues while not affecting surrounding tissues.
- suitable insulating materials such as Teflon which permits selective freezing of upper or lower tissues while not affecting surrounding tissues.
- Teflon Teflon which permits selective freezing of upper or lower tissues while not affecting surrounding tissues.
- the skin lesion can be elevated from the underlying structures. This avoids complications as nerve destruction which will occur using other techniques.
- the above-described techniques can be used in the skin or mucous membranes and also in the body cavities as the oral cavity, vaginal, nose and others as the curved needles direct the exit of gas towards its source and also by the use of a suction machine or isolated cones or tubes the discharged gas can be directed accordingly. The gas in this manner can be extracted safely from the body cavity.
- the method and apparatus above described can be used to produce limited destruction of tissues by using a cyrogen with minimal or without surface affection. In this manner one can eliminate unwanted tissues without surgery or without unnecessary openings of the skin. These techniques will therefore prevent the hazards and complications of such surgery and avoid the use of general anesthesia and therefore prevent scar formation or a bleeding field.
- the technique can be used in the palliative treatment of inoperable tumors and can be used to reduce the size or relieve compression of malignant tumors and metastasis without the need of wound protection or prolonged wound healing or dressing.
- the application of external compression on a straight part of a needle which is passed through a dialated vein the lumen can be sclerossed and obliterated.
- two or more isolated lower surface needles can be used simultaneously in a cross axis manner to produce destruction in the central focus of an area through simultaneous multisources of freezing.
- the techniques described above are usually used without anesthesia since the needles produce a pain similar to the pain incurred during an ordinary needle prick.
Abstract
There is described a method of performing intra-lesional cryosurgery utilizing a specifically shaped tubular needle having a front piercing surface coextensive with an opening. The needle is introduced into the skin from one point and runs through deeper tissues based on the surface orientation of the needle. The piercing surface of the needle is directed through a second point where it emerges from the skin. The needle as indicated is a hollow tubular member and has one end which is adapted to receive a source of a cryrogen gas. The gas is passed through the needle and produces a lowering of the needle temperature. This low temperature is directed to the surrounding tissues to form an ice cylinder about the imbedded part of the needle in the deeper tissues. This ice cylinder affords to selectively freeze the tissue and thereby destroys the lesion being treated. A plurality of different shaped needles are shown to accommodate different types and different depth lesions. Some needles are also selectively insulated at various portions to cause the uninsulated portion of the needle to selectively apply freezing temperatures to tissues in selective directions.
Description
This invention relates to a method and apparatus for applying cryotherapy and more particularly to apparatus and methods employing specifically shaped elongated tubular needles inserted through the skin of a patient to destroy lesions by passing a cryogen through the needle.
Cryogenics are primarily concerned with the development of freezing temperatures within a biological system. Thus use of cryogenics in medicine dates back to the ancient Egyptians of 2500 BC as they found that the application of cold soothes sites of trauma and reduces inflammation.
See a text entitled "Cryosurgery-For Skin Cancer and Cutaneous Disorders" edited by Setrag A. Zacarian, published by The C. V. Mosby Company (1985), St. Louis, Toronto, Princeton.
The destruction of tissue by local application of refrigerants is an established surgical technique. When controlled, it will provide precise injury and at the same time spare neighboring vital structures.
Cryosurgery is based on withdrawal of heat from a biological system which will lead to freezing of the tissues and transformation of the water from solution into biologically inert ice crystals. In turn this will lead to cessation of circulation in the tissues with intra- and extra-cellular biochemical, anatomical and physiological sequel which will end in tissue anoxemia and ischemic necrosis.
The critical temperature at which cells die when they are frozen may occur between -2° C. and -4° C. It was found that -50° C. is the optimal temperature for achieving effective cryonecrosis of malignant tumors of the skin.
The two most commonly used refrigerants in cryosurgery are nitrous oxide (N2 O) and liquid nitrogen (LN2). The latter is the only coolant effective for malignant tumors as it has a lower boiling point up to -195.6° C.
Cryosurgery is used for treating benign, premalignant and some cutaneous malignant lesions. In addition, it was found to be useful for palliative therapy of malignant conditions.
Two main techniques for cryosurgery application are reported in the literature. A spray technique (ST) in which cryogen is applied directly onto the target site and a cryoprobe technique (CP) in which the surface of the previously cooled probe (by the cryogen) is applied to the target site instead of the actual cryogen. See a text entitled "Skin Surgery" edited by E. Epstein, 5th Edition, Charles C. Thomas, publisher, Springfield, Ill.
The shape of the cryolesion (produced by application of either technique to the surface) is hemispherical as the ice front advances from the surface downward. This hemispherical ice ball cannot be perceived during the freezing procedure but it can be balloted by palpitation, which is adequate for the most superficial lesions, but it is of little value for the common nodular carcinomas of the skin which need measuring of the temperature in depth through thermocouple needles or other apparatus. The rate of extension of freezing slows as conditions at the periphery approach equilibrium between heat loss and heat supply by circulation. In general, the depth of freezing may be judged by the lateral spread of frost from the probe and this is used as a guide in treatment. It is just about the radius of the surface area and about half the radius of the ice ball in the cryo-spray technique.
The choice of technique is based in part on technical consideration but also in part on personal preference. The advantage of a probe technique is that it produces a more predictable area freezing, deeper penetration in addition to the possibility of pressure on the probe which increases the depth of penetration through compression of the tissue. Cryo-probes may be either applied to the surface of a lesion or inserted into the tissues (especially pointed probes) to produce deep freezing. Surface freezing with application of slight pressure is used more commonly than probe insertion as it has the advantages that no wound is caused, little or no bleeding occurs, need for anesthesia is lessened and the danger of dissemination of tumor cells are minimized. On the other hand, insertion of the probe into the tissue has its advantage in that it increases efficiency of freezing because of greater contact with the freezing surface.
Presently available probes are employed by application of the probes to the surface of the skin to transmit the cold to deeper tissues. Due to the length of time required, this technique results in damage to the overlying tissue. Such probes are available from many concerns such as the Brymill Corporation of Vernon, Conn. 06066. To achieve cooling of the probe, the gas circulates inside its lumen. The probes contain an inlet conduit and an outlet conduit both of which are associated with a probe tip. Hence, larger probes which can perform deeper penetration are wide and have diameters in excess of 3 mm. Hence, these probes are employed together with surgical procedures using scalpels, punch biopsy, electrocautery and so on. The use of the larger probes is limited due to the attendant surgical procedures requiring a large bleeding field and local anesthesia to enable the probe to be inserted at the proper depth.
There are thin probes which are about 1 mm in diameter and which are cooled by conduction. These probes are extremely short (less than 5 mm) and also require a surgical opening to reach the outer layers of the deeper tissues to be frozen.
The advantage of the spray technique is that the cryogenic agent is used at its coldest possible temperature and the spray can be moved freely about the lesion so that freezing can be extensive and wide rather than deep (as it does not compress tissues). The principal problem with the spray is that freezing is difficult to achieve and prolonged use in one area results in healthy tissue destruction. This is in addition to the possibility of gas insuflation of subcutaneous tissues and the possibility of infection with organisms which the gas may contain (as Staphylococcus albus).
The destruction of a deeper tissue by the commonly used techniques need more destruction of the superficial tissues as the cooling starts from above. This will lead usually to unwanted manifestations and uncommonly to some complications. The undesirable clinical manifestations start by wheal formation due to liberation of histamine from degranulated mast cells. This is usually followed by formation of a bulla due to dermal-epidermal separation while with deeper freezing the blister does not develop. The bulla may be hemorrhagic and sersanguineous exudate may persist coming out up to 10 days or more. Oedema and crust formation usually follow and complete re-epithelization may not take place (in some lesions) before two months of cryosurgery. In addition to the hypertropic scars and pigmentary disorders, other less common complications were reported as: pain, post-operative infection, debilitating oedema, development of pyogenic granuloma, and nerve damage. Also the possibility of nitrogen hypoxia exists when working near the nostrils or mouth. Although success in curing some lesions by cryosurgery (as Actinic Keratosis) may reach up to 98%, the problems of recurrence and incomplete cure differ among the lesions with different pathologic natures.
As a result, many authors did not find the ordinary methods and instrumentations of cryosurgery satisfactory in regard to ease of application, efficacy and optimum cosmetic results. This was especially true of lesions with different groups of patients especially poor risk patients because of the associated diseases and advanced age. So some investigators had been forced to modify the known techniques (ST, CP).
Some of the modifications concerned the instrumentation, as using different probes and using clear plastic cones to allow control of the lateral spray and visualization of the frost during freezing. Other modifications were concerned with the methods of application as debulking of the keratotic lesions, combination of electrocautery or partial excision or curretage with cryotherapy and application of both spray and probe techniques through the biopsy site.
In spite of the available modifications, the problem of producing and determining of effective freezing in depth seems to be still unsolved, a hope which attracted the effort of some investigators.
Some authors tried to use other aids to determine the depth of the ice front. Zacarian D., made an experiment using ultrasound and hoped for a visual demonstration of the evolving cryolesion. But, during the freezing state, the ultrasound was unable to detect the hemispherical ice formation or depth of the ice front below the skin surface and within the tumor. He stated that further devices should include the ability to visualize and measure the volume of the evolving cryolesion and detect the advancing hemispherical ice front during cryosurgery.
Gage A. stated that the chief limitation with cryosurgery is the difficulty in freezing sufficient tissue (especially for large cancers). The best of presently available apparatus is barely adequate because tissues are poor conductors of heat that limits extension of freezing. The amount of tissue that can be frozen in a single application of a probe is small in comparison with many lesions. Depth of freezing beyond 2 cm. is difficult to achieve. Multiple applications of the probe, insertion of the probe into bulky lesions and repetition of freezing at a later date are the methods of compensating for the difficulty of freezing sufficient tissue. Still these do not ensure capability of freezing large cancers. Inevitable advances in equipment design and improved techniques of freezing should help solve these problems.
In the description of the ideal apparatus for the application of liquid nitrogen; Elton R., mentioned that it should be simple to operate, safe to use, portable and should enable the operator to freeze to an adequate depth.
In trained hands cryosurgery has already proved to be a valuable tool. No doubt as improvements in equipment and techniques are developed, it will become even more valuable because of its unique properties.
The problems attendant with commercially available probes have been documented and the need for improved devices has been recognized.
See the following references:
1. Crumy H. M.,
Physical Modalities of Therapy, Chapter 38, Dermatology 2nd Ed., Moschella S. L., Hurley H. J., W. B. Saunders Co., Philadelphia 1985, pp 1996-2001
2. Elton R. F.
Cryosurgery for Skin Cancer and Cutaneous Disorders, Zacarian S. A., The C. V. Mosby Co., St. Louis, 1985, PP 313-321
3. Elton, R. F.
Complications of Cutaneous Cryosurgery J-Am.-Acad. Dermatol. April, 1983 (8) (4) PP 513-9
4. Gage A. A.
Deep Cryosurgery in Skin Surgery, Epstein E. Charles C. Thomas, Publisher, Springfield, 1982, pp 857-877
It is an object of the present invention to provide an improved method and apparatus for performing cryotherapy while avoiding the problems of the prior art.
It is a further object of the present invention to provide an improved probe which is of a needle-like configuration and adapted for insertion through the skin allowing a gas to be directed through the hollow of the needle and to be discharged from the needle into the atmosphere.
FIG. 1 is diagrammatic view showing a use of a needle according to this invention and employed with a cyrotherapeutic technique.
FIG. 2 is a diagrammatic view showing the needle of FIG. 1 being inserted through the skin.
FIG. 3 is a diagrammatic view showing the needle of FIG. 1 in position.
FIG. 4A is a diagrammatic view showing the needle coupled to a source of gas to remove or freeze a lesion according to the techniques and methods of this invention.
FIG. 4B is a diagrammatic view depicting the apparatus of FIG. 4A and showing one technique for determining the depth of freezing.
FIG. 5 is diagrammatic view depicting a transverse section of the treated area as in FIG. 4B showing the use of thermocouples to determine temperature.
FIGS. 6-8 are diagrammatic views employing the use of a hook-shaped needle according to this invention.
FIG. 9 is a diagrammatic view showing the use of the needle in FIGS. 6 and 7 as applied to a gaseous source.
FIG. 10 is a diagrammatic view of a partially insulated needle showing the use of such a needle to remove a particular lesion adjacent a body orifice.
FIG. 11 is a diagrammatic view of one particular needle according to this invention.
FIG. 11B depicts the needle of FIG. 11 used in a cyrotherapeutic procedure according to this invention.
FIG. 12 is a diagrammatic view of another needle employed according to this invention.
FIG. 12B depicts the needle of FIG. 12 used in a typical application according to this invention.
FIG. 13 shows a needle of a different configuration while FIG. 13B shows the needles of FIG. 13 utilized in a cyrosurgical procedure.
FIGS. 14 and 15 show two different needles of a fish-hook configuration having different gas discharge openings which openings are oriented in different directions.
FIGS. 14B and 15B show the needles of FIGS. 14 and 15 respectively used in a cyrotherapeutic operation.
FIGS. 16A to 21A depict various needle configurations employing different portions of insulation.
FIGS. 16B to 21B depict the needles in FIGS. 16A to 21A used in therapeutic applications.
FIGS. 22A and 23A depict alternate embodiments of needles employed with this invention.
FIGS. 22B and 23B depict needles in FIGS. 22A and 23A utilized in therapeutic applications.
FIGS. 24A and 25A depict alternate embodiments of insulated needles according to this invention.
FIGS. 24B and 25B show the needles of FIGS. 24A and 25A utilized in surgical procedures.
FIGS. 26A and 27A depict alternate embodiments of needles employed according to this invention.
FIGS. 26B and 27B show the needles of FIGS. 26A and 27A utilized in surgical procedures.
FIG. 28 shows the use of a multiplicity of needles employed during a surgical procedure and according to the methods described in this invention.
Referring to FIG. 1, there is shown a needle 10 which is employed in accordance with this invention. Also shown in FIG. 1 is the hand of a physician who is going to utilize the needle 10 in order to perform a cyro-therapeutic operation as the removal of a lesion from the patient.
As seen in FIG. 1 and as will be further evidenced in regard to the description to follow, each needle is composed of a shaft 11 and a headpiece 12. Essentially, the needle is a hollow tubular member having a sharpened point 14 which point 14 terminates in an opening. The headpiece 12 is the connecting part which connects the hollow shaft to the cyro-surgery apparatus. Essentially, the cyro-surgery apparatus is a source of cyrogen which for example may be liquid nitrogen or nitrous oxide. This source contains the pressurized cyrogen which is inserted into the needle via the headpiece 12. The headpiece 12 is of a conventional design and may be implemented in many different ways according to the source of cyrogen to be utilized.
Thus, the headpiece 12 may be a threaded screw member or some other coupling device to enable one to couple the needle and shaft into a source of pressurized gas. The headpiece 12 may be integrally formed with the shaft 11 and thus form a complete integral structure. The shaft 11 of the needle is formed of a strong and sterilizable material such as stainless steel.
It is understood as will be explained that due to the simple construction of the needle 10 it can be used in an operation and then disposed of. The shaft 11 may be of any diameter permitting easy effective cooling by the gas which is applied through the internal hollow of the shaft 11. The usually used diameters of needle 11 are between 0.5 to 1.0 millimeters. It is of course understood that the diameter employed may vary according to the particular procedure employed.
As can be seen from FIG. 1, the needle 10 has a bend forming an angle which angle may be up to 130°. A typical length of the shaft may be greater than 3.5 centimeters while typical lengths employed are between 8 to 16 centimeters to allow the headpiece 12 to be far enough from the surface of the skin to avoid and prevent any danger which may occur from contact with the cold parts of the apparatus or due to leakage.
This length is also selected to enable the practitioner to obtain a proper field of view while performing the method to be described.
As will be further described in conjunction with various other Figures, the shape of the needle may vary according to the particular techniques employed. As seen from FIG. 1, the physician grasps the skin above the affected proceeds to insert the needle from one point so that the needle passes through the skin as shown in FIG. 2 whereby the tip or point 14 passes directly through the area to be treated.
As seen in FIG. 3, the angle portion of the needle is then positioned to lie beneath the skin at a predetermined depth based on the formed angle. Thus, as one can immediately see from FIG. 3, the angle portion of the needle is located directly beneath the surface of the skin at a given depth while the point 14 is positioned within the atmosphere.
As shown in FIG. 4A, a source 20 containing a cyrogen is coupled to the headpiece 12. As one can see from FIG. 4A, the gas is passed through the needle thus lowering the temperature as well as the temperature of the surrounding tissue. The gas as seen in FIG. 4A is discharged via the point opening 14 into the atmosphere. The patient's skin which is under both the visible parts of the needle is protected by suitable sheets 15 of insulating material such as Teflon, nylon, paper towels or any other suitable material. This material 15 is used to protect the patient's skin from contact with the visible cold parts of the needle.
Thus, as seen in FIG. 4A, an ice cylinder designated by the dashed lines will be formed around the imbedded part of the needle in the deeper tissues. The temperature can be lowered by increasing the time of gas passage until a desired temperature is reached. As one can ascertain from the description above, the needle shown in FIG. 1 contains a bend and is angulated with the direction of the opening 14 being in the upward direction. It is of course understood that the bend may be located at any point along the shaft as between the junction of the interior third with the posterior third or at the middle of the needle. The angle as indicated may be more or less than 130°, but 130° is considered desirable.
As will be further explained, there are many configurations which will be employed to accommodate needles including needles which are insulated partially to allow one to effectuate concentrated freezing in desired directions or locations. These needles employing other configurations will be explained. In any event, it should be understood from the above description that the main objective of the present invention is to provide a specifically shaped needle which needle for example contains a shaped area allowing deep penetration into the skin. The needle being of a small diameter and having a sharpened point can then be inserted at any desired depth. By means of a headpiece associated with the hollow shaft, a source of cyrogen can be accommodated and pass through the needle. The needle will allow the gas to be discharged due to the fact that the needle is inserted into the skin and then pushed so that the point end and opening is pushed through the skin. In this manner the physician utilizes the needle in the simple procedure shown in FIGS. 1-4A and eliminates the necessity of performing any surgical procedures as well as eliminating the need for providing the patient with an anesthetic due to the simple procedures involved.
Referring to FIG. 4B, there is shown the apparatus of FIG. 4A wherein the gas is being passed through the hollow of the needle 11. Essentially, the physician can determine the extension of whitish freezing areas as 21 and 22 around the points of contact between the surface and the appropriate portions of the needle. This whitish area represents another indicator for the determination of the extent of freezing.
In regard to FIG. 5 there is shown two thermocouple probes 27 and 26. The thermocouple needles are inserted into the area being treated by the needle 11 and are utilized to measure the temperature of the area to determine proper freezing of the area.
Referring to FIGS. 6-9, there is shown a different needle configuration and a procedure which is accomplished utilizing the needle.
As seen in FIG. 6, the needle 31 is curved or of a hook shape configuration. The needle 31 again has a hollow shaft having an opening 32 to allow gas inserted into the needle by means of a headpiece 12 (not shown) to be discharged into the atmosphere. To the right of FIG. 6, there are shown two views showing the surgeon's hands in raising the skin so that the needle can be inserted as shown in FIG. 7 and then, as indicated in FIG. 8, is pushed so that the opening 32 now extends from the skin.
FIG. 9 shows the same needle 31 accommodating a source of cryogen 36 which is applied to the needle via the headpiece 35. As one can ascertain from FIG. 9, the gas is discharged accordingly. Also shown in FIG. 9 is a clamp 37 which is an insulated clamp and which is held by the physician while directing gas through the needle 31 to enable the physician or an assistant to pull upwardly. The dashed line area shows the area of freezing which would be accommodated utilizing the needle depicted in FIG. 9.
Referring to FIG. 10, there is shown still another example of a hook shaped needle 40. The needle 40 has a layer 41 of insulating material such as a Teflon disposed on a surface. As seen from FIG. 10, the Teflon layer 41 is disposed along the arcuate section of the needle and along the shaft section leaving a portion 43 unexposed. Shown to the left of the needle is a tumor location 50 which essentially is a deep tumor.
As seen from FIG. 10, the needle 40 is then inserted into the skin by means of the above-described techniques and the cryogen gas is applied to the hollow of the needle with the aperture 42 allowing the gas to be expelled and sprayed away from the patient.
FIGS. 11 and 12 depict two different needles 50 and 51 wherein the angle of the bend is less in FIG. 11 than it is in FIG. 12. It is of course understood that both needles can be employed to freeze different types of lesions at different depths. It is also understood that both needles have associated therewith a suitable headpiece for coupling to a source of gas.
FIG. 11B shows the use of the needle 50 in regard to a surface lesion 60 while FIG. 12B shows the use of the needle 51 in regard to another surface legion 61.
FIG. 13 shows another needle configuration 62.
FIG. 13B shows a needle 62 operating in conjunction with a lesion 63. It is shown that needle 62 is arcuate in configuration having less of a curve then for example the needle shown in FIG. 10.
Referring to FIGS. 14 and 15, there is shown two needles 70 and 71 basically each having a straight shaft with the distal end being curved as part of a circle. In any event, as one can ascertain, the opening 72 associated with needle 71 is directed towards the inside of the circle while the opening 73 associated with needle 70 is directed away from the circle. The direction of gas flow is shown in FIGS. 14 and 15.
FIGS. 14 and 15 indicate that the openings in regard to the tip of the needle can be oriented in different planes to therefore direct or discharge the gas in different directions depending upon the particular surgery to be performed.
FIGS. 14B and 15B show the use of the two different types of needles depicted in FIGS. 14 and 15 as being utilized to freeze different types of lesions.
FIGS. 16A-21A depict a series of needles having different sections thereof insulated to allow the needle to be utilized to selectively freeze lesions of different sizes and different depths. FIGS. 16B-21B show the needles employed with different lesions. As one can determine, the needle shown in FIG. 16B has a shaft 80 which is insulated in area 81 and 82 leaving the central portion or angular portion exposed. The needle is used to freeze a lesion 83.
FIG. 17B shows still another needle configuration having a different angular configuration. The needle 84 has areas 85 and 86 which are insulated leaving the angular portion again uninsulated and utilized to remove a lesion 87 shown
FIG. 20B shows still another needle 88 having an insulated portion 89, a central insulated portion 90 and an end portion 91. It is noted that the portion 90 associated with the angular bend is insulated at the bottom surface and uninsulated at the top surface and is utilized to freeze a lesion such as 92.
FIG. 21B shows still another needle whereby the angular portion or section is uninsulated at the top surface having insulated section 94 and 95 adjacent to the same and is utilized to remove or freeze a lesion designated by reference numeral 96.
FIGS. 18A, 19A, 18B and 19B show needles which are of hook shaped configurations having different sections thereof insulated with the needle 100 shown in FIG. 19A having a different direction opening from the needle 102 shown in FIG. 18A.
FIGS. 18B and 19B show the needles of 18A and 19A employed to remove tumors as 110 and 111 with saving of the surface tissue.
Referring to FIGS. 23A and 22A, there again is shown bent needles having insulation applied around the outside surfaces thereof near the arcuate bends allowing a portion of the needle to be exposed such as portions 115 and 116. It is noted that the difference between the needles in 23A and 22A involve the directional openings as 117 and 118.
FIGS. 23B and 22B show the needles of FIGS. 22A and 23A being employed to remove tumors 130 and 131 with the direction of gas being discharged through the different orifices in different directions and allowing freezing to occur only in the center.
FIGS. 24A and 25A show two different needle configurations 120 and 121 having selective areas covered with insulation to allow the bottom portions of the needle to effectuate freezing in FIGS. 24B and 25B. These are used for obliterations of small blood vessels and other superficial linear lesions.
FIGS. 26A and 27A show again different arcuate shaped needles 122 and 123 having the bottom portions thereof insulated to allow the removal of certain types of tumors as indicated in FIGS. 27B and 26B with sparing of deeper tissues.
FIG. 28 shows the use of multiple needles 125 and 126 to freeze a given lesion. It is thus obvious that one can utilize multiple needles to effectuate freezing of various different types of tissue at the same time or afterwards.
Thus, from the above it should be apparent to those skilled in the art that various specifically shaped needles may be employed. In any event, all needles are introduced into the skin of a patient by the same technique. All needles accommodate the cryogen or gas by the same type of system. The curve or angle of the needle is a function of the penetration desired and is a function of the depth at which the needle is to be utilized.
Based on such techniques, certain surface portions of the needle can be insulated by the use of suitable insulating materials such as Teflon which permits selective freezing of upper or lower tissues while not affecting surrounding tissues. Thus, for example in regard to the needles depicted in FIGS. 26A and 26B, one can understand that based on the insulation of the outer half surface, freezing occurs only from the inner or upper half surface of the needles. This will allow freezing of the central tissues including the surface so that the extent of freezing will be apparent on the surface. The insulated needles as depicted thus serve multiple purposes and essentially save and avoid damage to surrounding healthy tissues.
As one can ascertain from the above, most of the lesions of the skin which need local excision whether benign, premalignant or malignant can be destroyed easily with minimum local reactions (as edema and haemorrhagic bulla and serous exudation). These usually occur when the cyrosurgery is applied to the surface to reach the deeper tissues. In any event, by the use of the needles as explained and described above, cyrosurgery starts at the required depth directly by insertion of the needles. The above described needles can be imbedded in any part of a lesion to produce upper, middle or lower destruction or can be imbedded around the lesion to destroy the blood supply and surround the lesion by fibrous tissue.
As is also shown in the above-noted Figures, by gentle pulling of the imbedded needle in an upward direction, the skin lesion can be elevated from the underlying structures. This avoids complications as nerve destruction which will occur using other techniques. The above-described techniques can be used in the skin or mucous membranes and also in the body cavities as the oral cavity, vaginal, nose and others as the curved needles direct the exit of gas towards its source and also by the use of a suction machine or isolated cones or tubes the discharged gas can be directed accordingly. The gas in this manner can be extracted safely from the body cavity.
The method and apparatus above described can be used to produce limited destruction of tissues by using a cyrogen with minimal or without surface affection. In this manner one can eliminate unwanted tissues without surgery or without unnecessary openings of the skin. These techniques will therefore prevent the hazards and complications of such surgery and avoid the use of general anesthesia and therefore prevent scar formation or a bleeding field.
The technique can be used in the palliative treatment of inoperable tumors and can be used to reduce the size or relieve compression of malignant tumors and metastasis without the need of wound protection or prolonged wound healing or dressing. As seen for example in FIGS. 24B and 25B, the application of external compression on a straight part of a needle which is passed through a dialated vein the lumen can be sclerossed and obliterated. In this manner as shown in FIG. 28 two or more isolated lower surface needles can be used simultaneously in a cross axis manner to produce destruction in the central focus of an area through simultaneous multisources of freezing. The techniques described above are usually used without anesthesia since the needles produce a pain similar to the pain incurred during an ordinary needle prick.
Furthermore, since the cold gas has an anesthetizing capacity local anesthesia is not resorted to except in unusual cases.
Claims (21)
1. A method of applying intra-lesional cryotherapy, comprising the steps of:
inserting a hollow thermally conductive needle having a front opening through the skin of a patient with said needle having a given surface portion adapted to position the same at a given depth according to the location of a lesion to cause said front opening of the needle to protrude from the patient's skin when said given portion is in position and applying a cryogen through the internal hollow of said needle to cause said given portion to freeze tissue in the area of said lesion while said cryogen is being discharged from said front opening of said needle.
2. The method according to claim 1, wherein said given portion of said needle includes a bend at a predetermined angle.
3. The method according to claim 1, further including the step of placing an insulating material about the skin of the patient after inserting said needle to protect the skin during the application of said cryogen.
4. The method according to claim 1, wherein said front opening of said needle is contiguous with a sharp tip for penetrating the skin.
5. The method according to claim 1, wherein the step of inserting includes inserting a needle having a hook-like front portion into the skin of a patient with the hook portion constituting said given portion and having a front which protrudes from the skin for discharging said cryogen.
6. The method according to claim 1, including the further step of selectively insulating portions of said needle prior to insertion of the same to form said given portion of a predetermined configuration.
7. The method according to claim 1, wherein said needle has a diameter between 0.5-1.0 mm and a length greater than 3 cm.
8. The method according to claim 7, wherein the length of said needle is between 8-16 cm.
9. The method according to claim 1, wherein said cyrogen is selected from nitrous oxide and liquid nitrogen.
10. The method according to claim 6, wherein the step of selectively insulating portions of said needle prior to insertion of the same includes insulating said portions with Teflon.
11. The method according to claim 1, further including the step of pulling said needle upwardly while applying said cryogen to raise said skin during application.
12. A method of performing cryosurgery on a lesion associated with the skin of a patient, comprising the steps of:
inserting a relatively long hollow thermally conducting tubular needle through the skin of a patient in the area of said lesion, said needle having a sharpened apex surrounded by a front opening at a first end and having an opening at a second end with said needle having a given shaped portion that is positioned in the area of said lesion when said needle is inserted such that said front opening protrudes from the patient's skin,
applying a source of cryogen to said opening at said second end to cause said cryogen to pass through the hollow of said needle and to be discharged through said front opening to freeze tissue in the vicinity of said lesion.
13. The method according to claim 12, wherein the step of inserting includes inserting a hollow stainless steel needle having a bent given shaped portion.
14. The method according to claim 12, wherein the step of inserting includes inserting a hollow stainless steel needle having an arcuate given shaped portion.
15. The method according to claim 12, further including the step of selectively insulating portions of said needle prior to insertion to provide a selected surface area for conduction to selectively freeze said tissue.
16. The method according to claim 12, further including the step of placing an insulating material about the skin of said patient after inserting said needle to protect the skin while applying said cryogen.
17. The method according to claim 12, further including the step of pulling said needle during the application of said cryogen to raise the skin of the patient in said area of said lesion.
18. The method according to claim 12, wherein said front opening is canted to discharge said cryogen in a given direction.
19. A probe to be employed in a cryosurgical operation comprising:
a hollow thermal conducting tubular needle having a front opening at a first end and back opening at a second end, said tubular needle having a given surface portion between said ends of a shape to allow said needle to be inserted into the skin of a patient at a given depth according to the location of a lesion to be removed by freezing the tissue in the area of said lesion with said given surface portion always allowing said front opening at said first end to protrude from the skin of a patient when said needle is inserted to allow cryogen to escape into the atmosphere, means coupled to said second end and adapted to receive a source of a cryogen, including an insulator material surrounding surface portions of said needle which insulated surface portions define a given thermal conducting non-insulated region for selectively freezing said lesion.
20. The probe according to claim 19, wherein said given surface portion is manifested by an angular bend in said tubular needle between said first and second ends.
21. The probe according to claim 19, wherein said surface portion is manifested by an arcuate curve in said tubular needle between said first and second ends.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/064,619 US4802475A (en) | 1987-06-22 | 1987-06-22 | Methods and apparatus of applying intra-lesional cryotherapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/064,619 US4802475A (en) | 1987-06-22 | 1987-06-22 | Methods and apparatus of applying intra-lesional cryotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
US4802475A true US4802475A (en) | 1989-02-07 |
Family
ID=22057175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/064,619 Expired - Fee Related US4802475A (en) | 1987-06-22 | 1987-06-22 | Methods and apparatus of applying intra-lesional cryotherapy |
Country Status (1)
Country | Link |
---|---|
US (1) | US4802475A (en) |
Cited By (200)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200170A (en) * | 1989-07-18 | 1993-04-06 | Mcdow Ronald A | Medical process--use of dichlorodifluoromethane (CCl2 F2) and chlorodifluoromethane (CHClF2) as cryogens for treating skin lesions |
WO1995030380A2 (en) * | 1994-05-10 | 1995-11-16 | Spembly Medical Limited | Cryosurgical instrument |
US5571147A (en) * | 1993-11-02 | 1996-11-05 | Sluijter; Menno E. | Thermal denervation of an intervertebral disc for relief of back pain |
WO1996037158A1 (en) * | 1995-04-28 | 1996-11-28 | Chinn Douglas O | Cryosurgical integrated control monitoring system and method |
US5647868A (en) * | 1994-02-02 | 1997-07-15 | Chinn; Douglas Owen | Cryosurgical integrated control and monitoring system and method |
US5733280A (en) * | 1995-11-15 | 1998-03-31 | Avitall; Boaz | Cryogenic epicardial mapping and ablation |
WO1998017187A1 (en) * | 1996-10-22 | 1998-04-30 | Heartport, Inc. | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US5976505A (en) * | 1997-07-02 | 1999-11-02 | Hcs Trust | Method for cryogenically treating psoriasis with liquid nitrogen or liquid nitrous oxide |
US6237605B1 (en) | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6241722B1 (en) | 1998-06-17 | 2001-06-05 | Cryogen, Inc. | Cryogenic device, system and method of using same |
WO2001041683A2 (en) * | 1999-12-07 | 2001-06-14 | Dieter Steinfatt | Applicator for the application of cryogenic refrigerants and application device |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6401722B1 (en) * | 1998-06-12 | 2002-06-11 | Calypso Medical Technologies, Inc. | Method for stabilizing and removing tissue |
US20020107513A1 (en) * | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with thin electrodes |
US20020138109A1 (en) * | 2001-01-13 | 2002-09-26 | Medtronic, Inc. | Method and system for organ positioning and stabilization |
US20020173784A1 (en) * | 1996-10-22 | 2002-11-21 | Epicor, Inc. | Methods and devices for ablation |
US6503246B1 (en) * | 2000-07-05 | 2003-01-07 | Mor Research Applications Ltd. | Cryoprobe and method of treating scars |
US6517536B2 (en) | 2000-04-27 | 2003-02-11 | Atricure, Inc. | Transmural ablation device and method |
US20030191462A1 (en) * | 1996-05-03 | 2003-10-09 | Jacobs Clemens J. | Method for interrupting conduction paths within the heart |
US6645202B1 (en) | 1996-10-22 | 2003-11-11 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US20030220674A1 (en) * | 2002-03-15 | 2003-11-27 | Anderson Richard Rox | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US20040015219A1 (en) * | 2002-05-16 | 2004-01-22 | Francischelli David E. | Device and method for ablation of cardiac tissue |
US20040015106A1 (en) * | 2000-01-19 | 2004-01-22 | Coleman R. Glen | Focused ultrasound ablation devices having selectively actuatable emitting elements and methods of using the same |
US6689128B2 (en) | 1996-10-22 | 2004-02-10 | Epicor Medical, Inc. | Methods and devices for ablation |
US20040049179A1 (en) * | 2001-04-26 | 2004-03-11 | Francischelli David E. | Ablation system |
US20040078069A1 (en) * | 2001-12-11 | 2004-04-22 | Francischelli David E. | Method and system for treatment of atrial tachyarrhythmias |
US20040087941A1 (en) * | 1998-05-20 | 2004-05-06 | Wang Paul J. | Cardiac system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6761715B2 (en) | 2001-04-26 | 2004-07-13 | Ronald J. Carroll | Method and device for neurocryo analgesia and anesthesia |
US20040138621A1 (en) * | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US20040138656A1 (en) * | 2000-04-27 | 2004-07-15 | Francischelli David E. | System and method for assessing transmurality of ablation lesions |
US20040143260A1 (en) * | 2001-04-26 | 2004-07-22 | Francischelli David E. | Method and apparatus for tissue ablation |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US20040215294A1 (en) * | 2003-01-15 | 2004-10-28 | Mediphysics Llp | Cryotherapy probe |
US20040215183A1 (en) * | 1995-02-22 | 2004-10-28 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US20040220560A1 (en) * | 2003-04-29 | 2004-11-04 | Briscoe Roderick E. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US20040236322A1 (en) * | 1997-07-18 | 2004-11-25 | Mulier Peter M.J. | Device and method for ablating tissue |
US20040267326A1 (en) * | 2002-01-25 | 2004-12-30 | Ocel Jon M | Cardiac mapping instrument with shapeable electrode |
US20050033284A1 (en) * | 2000-04-27 | 2005-02-10 | Hooven Michael D. | Transmural ablation device with integral EKG sensor |
US6905498B2 (en) | 2000-04-27 | 2005-06-14 | Atricure Inc. | Transmural ablation device with EKG sensor and pacing electrode |
US20050149064A1 (en) * | 2002-06-25 | 2005-07-07 | Peterson James A. | Method and apparatus for tissue fastening with single translating trigger operation |
US20050165392A1 (en) * | 2002-01-25 | 2005-07-28 | Medtronic, Inc. | System and method of performing an electrosurgical procedure |
US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
US20050209564A1 (en) * | 2001-01-13 | 2005-09-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20050234444A1 (en) * | 2004-04-14 | 2005-10-20 | Hooven Michael D | Electrode and bipolar ablation method using same |
US20050251120A1 (en) * | 2002-03-15 | 2005-11-10 | Anderson Richard R | Methods and devices for detection and control of selective disruption of fatty tissue during controlled cooling |
US20050256522A1 (en) * | 2004-05-12 | 2005-11-17 | Medtronic, Inc. | Device and method for determining tissue thickness and creating cardiac ablation lesions |
US20050267454A1 (en) * | 2000-01-19 | 2005-12-01 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US20050273006A1 (en) * | 2000-10-10 | 2005-12-08 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US20060009760A1 (en) * | 1998-07-07 | 2006-01-12 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US20060009756A1 (en) * | 2004-05-14 | 2006-01-12 | Francischelli David E | Method and devices for treating atrial fibrillation by mass ablation |
US20060009759A1 (en) * | 2004-06-02 | 2006-01-12 | Chrisitian Steven C | Loop ablation apparatus and method |
US20060020271A1 (en) * | 2004-06-18 | 2006-01-26 | Stewart Mark T | Methods and devices for occlusion of an atrial appendage |
US20060020263A1 (en) * | 2004-06-02 | 2006-01-26 | Rothstein Paul T | Clamping ablation tool and method |
US20060025756A1 (en) * | 2000-01-19 | 2006-02-02 | Francischelli David E | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US20060036236A1 (en) * | 2004-06-02 | 2006-02-16 | Rothstein Paul T | Compound bipolar ablation device and method |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20060041254A1 (en) * | 2002-10-30 | 2006-02-23 | Medtronic, Inc. | Electrosurgical hemostat |
US20060047278A1 (en) * | 2004-06-02 | 2006-03-02 | Christian Steven C | Ablation device with jaws |
US20060052770A1 (en) * | 1998-07-07 | 2006-03-09 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US20060089630A1 (en) * | 2003-04-24 | 2006-04-27 | Swanson David K | Therapeutic apparatus having insulated region at the insertion area |
US7083612B2 (en) | 2003-01-15 | 2006-08-01 | Cryodynamics, Llc | Cryotherapy system |
US20060184167A1 (en) * | 1996-10-22 | 2006-08-17 | Matthias Vaska | Methods and devices for ablation |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US20060229594A1 (en) * | 2000-01-19 | 2006-10-12 | Medtronic, Inc. | Method for guiding a medical device |
US20060270900A1 (en) * | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
US7166105B2 (en) | 1995-02-22 | 2007-01-23 | Medtronic, Inc. | Pen-type electrosurgical instrument |
US20070049920A1 (en) * | 2000-03-06 | 2007-03-01 | Tissuelink Medical, Inc. | Fluid-Assisted Medical Devices, Fluid Delivery Systems and Controllers for Such Devices, and Methods |
US20070088344A1 (en) * | 2005-10-17 | 2007-04-19 | Galil Medical Ltd. | Endometrial ablation device and method |
US20070118107A1 (en) * | 2000-04-27 | 2007-05-24 | Francischelli David E | Vibration sensitive ablation device and method |
US20070129714A1 (en) * | 2005-05-20 | 2007-06-07 | Echo Healthcare Llc | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (FAT) |
US7250048B2 (en) | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US20070198071A1 (en) * | 2006-02-22 | 2007-08-23 | Juniper Medical Systems | Cooling device for removing heat from subcutaneous lipid-rich cells |
US20070213705A1 (en) * | 2006-03-08 | 2007-09-13 | Schmid Peter M | Insulated needle and system |
US7273479B2 (en) | 2003-01-15 | 2007-09-25 | Cryodynamics, Llc | Methods and systems for cryogenic cooling |
US20070225697A1 (en) * | 2006-03-23 | 2007-09-27 | Ketan Shroff | Apparatus and methods for cardiac ablation |
US7288092B2 (en) | 2003-04-23 | 2007-10-30 | Atricure, Inc. | Method and apparatus for ablating cardiac tissue with guide facility |
US20070255362A1 (en) * | 2006-04-28 | 2007-11-01 | Juniper Medical, Inc. | Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells |
US7291161B2 (en) | 2002-10-02 | 2007-11-06 | Atricure, Inc. | Articulated clamping member |
US20070282324A1 (en) * | 1999-07-19 | 2007-12-06 | Matthias Vaska | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US20080015562A1 (en) * | 2001-04-26 | 2008-01-17 | Medtronic, Inc. | Transmural ablation systems and methods |
US20080039746A1 (en) * | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US20080077211A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20080077202A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Tissue Treatment Methods |
US20080077201A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling devices with flexible sensors |
US20080091195A1 (en) * | 1998-09-21 | 2008-04-17 | Sliwa John W | Apparatus and method for ablating tissue |
US20080110182A1 (en) * | 2006-11-10 | 2008-05-15 | Vancelette David W | Coaxial Cryogenic Refrigeration Coupler |
US20080119838A1 (en) * | 2006-11-17 | 2008-05-22 | Vancelette David W | Disposable Sheath with Replaceable Console Probes for Cryosurgery |
US20080140061A1 (en) * | 2006-09-08 | 2008-06-12 | Arbel Medical Ltd. | Method And Device For Combined Treatment |
US20080183164A1 (en) * | 2005-05-20 | 2008-07-31 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20080208181A1 (en) * | 2007-01-19 | 2008-08-28 | Arbel Medical Ltd. | Thermally Insulated Needles For Dermatological Applications |
US7435250B2 (en) | 2000-04-27 | 2008-10-14 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US20080275439A1 (en) * | 2002-01-25 | 2008-11-06 | David Francischelli | Cardiac ablation and electrical interface system and instrument |
US20080287839A1 (en) * | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
US20090018623A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | System for treating lipid-rich regions |
US20090018625A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Managing system temperature to remove heat from lipid-rich regions |
US20090018626A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | User interfaces for a system that removes heat from lipid-rich regions |
US20090018624A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Limiting use of disposable system patient protection devices |
US20090062737A1 (en) * | 2007-08-28 | 2009-03-05 | Sun William Y | Ice coated hypodermic needle |
US20090093809A1 (en) * | 2007-10-05 | 2009-04-09 | Anderson Evan R | Devices and methods for minimally-invasive surgical procedures |
US20090129946A1 (en) * | 2007-11-21 | 2009-05-21 | Arbel Medical, Ltd. | Pumping unit for delivery of liquid medium from a vessel |
US20090126910A1 (en) * | 2007-11-19 | 2009-05-21 | International Businiess Machines Corporation | Apparatus and method for facilitating servicing of a liquid-cooled electronics rack |
US20090222001A1 (en) * | 2007-12-28 | 2009-09-03 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Devices, Methods and Systems |
US20090248001A1 (en) * | 2007-11-14 | 2009-10-01 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US20090299365A1 (en) * | 2008-05-13 | 2009-12-03 | Medtronic , Inc. | Tissue Lesion Evaluation |
US20090299357A1 (en) * | 2006-04-24 | 2009-12-03 | Thomas Jefferson University | Cryoneedle and cryotheraphy system |
US20100042110A1 (en) * | 2004-06-18 | 2010-02-18 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
US20100081971A1 (en) * | 2008-09-25 | 2010-04-01 | Allison John W | Treatment planning systems and methods for body contouring applications |
US20100145361A1 (en) * | 2004-06-18 | 2010-06-10 | Francischelli David E | Methods and Devices for Occlusion of an Atrial Appendage |
US20100152824A1 (en) * | 2008-12-17 | 2010-06-17 | Allison John W | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
US20100162730A1 (en) * | 2007-06-14 | 2010-07-01 | Arbel Medical Ltd. | Siphon for delivery of liquid cryogen from dewar flask |
US20100198216A1 (en) * | 2009-02-02 | 2010-08-05 | Palanker Daniel V | Electro-thermotherapy of tissue using penetrating microelectrode array |
US20100217255A1 (en) * | 2009-02-23 | 2010-08-26 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Device and Methods of Use Thereof |
US20100234670A1 (en) * | 2009-03-12 | 2010-09-16 | Eyal Shai | Combined cryotherapy and brachytherapy device and method |
US20100241114A1 (en) * | 2009-03-20 | 2010-09-23 | Salvatore Privitera | Cryogenic probe |
US7818039B2 (en) | 2000-04-27 | 2010-10-19 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US7824399B2 (en) | 2001-04-26 | 2010-11-02 | Medtronic, Inc. | Ablation system and method of use |
US20100280582A1 (en) * | 2009-04-30 | 2010-11-04 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US20100281917A1 (en) * | 2008-11-05 | 2010-11-11 | Alexander Levin | Apparatus and Method for Condensing Contaminants for a Cryogenic System |
US20100305439A1 (en) * | 2009-05-27 | 2010-12-02 | Eyal Shai | Device and Method for Three-Dimensional Guidance and Three-Dimensional Monitoring of Cryoablation |
US20100324546A1 (en) * | 2007-07-09 | 2010-12-23 | Alexander Levin | Cryosheath |
US20110015624A1 (en) * | 2008-01-15 | 2011-01-20 | Icecure Medical Ltd. | Cryosurgical instrument insulating system |
US7938822B1 (en) | 2010-05-12 | 2011-05-10 | Icecure Medical Ltd. | Heating and cooling of cryosurgical instrument using a single cryogen |
US20110125146A1 (en) * | 2009-09-08 | 2011-05-26 | Salient Surgical Technologies, Inc. | Cartridge Assembly For Electrosurgical Devices, Electrosurgical Unit And Methods Of Use Thereof |
US7967815B1 (en) | 2010-03-25 | 2011-06-28 | Icecure Medical Ltd. | Cryosurgical instrument with enhanced heat transfer |
US7967814B2 (en) | 2009-02-05 | 2011-06-28 | Icecure Medical Ltd. | Cryoprobe with vibrating mechanism |
US20110238050A1 (en) * | 2010-01-25 | 2011-09-29 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods |
US8080005B1 (en) | 2010-06-10 | 2011-12-20 | Icecure Medical Ltd. | Closed loop cryosurgical pressure and flow regulated system |
US8083733B2 (en) | 2008-04-16 | 2011-12-27 | Icecure Medical Ltd. | Cryosurgical instrument with enhanced heat exchange |
US8285390B2 (en) | 2007-08-21 | 2012-10-09 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US8409185B2 (en) | 2007-02-16 | 2013-04-02 | Myoscience, Inc. | Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling |
US8512337B2 (en) | 2001-04-26 | 2013-08-20 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US8568409B2 (en) | 2000-03-06 | 2013-10-29 | Medtronic Advanced Energy Llc | Fluid-assisted medical devices, systems and methods |
US20140026395A1 (en) * | 2010-05-28 | 2014-01-30 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical devices, and methods of manufacture thereof |
US8663245B2 (en) | 2004-06-18 | 2014-03-04 | Medtronic, Inc. | Device for occlusion of a left atrial appendage |
US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US8870864B2 (en) | 2011-10-28 | 2014-10-28 | Medtronic Advanced Energy Llc | Single instrument electrosurgery apparatus and its method of use |
US8906012B2 (en) | 2010-06-30 | 2014-12-09 | Medtronic Advanced Energy Llc | Electrosurgical devices with wire electrode |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US9017318B2 (en) | 2012-01-20 | 2015-04-28 | Myoscience, Inc. | Cryogenic probe system and method |
US9066712B2 (en) | 2008-12-22 | 2015-06-30 | Myoscience, Inc. | Integrated cryosurgical system with refrigerant and electrical power source |
US9138289B2 (en) | 2010-06-28 | 2015-09-22 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US9155584B2 (en) | 2012-01-13 | 2015-10-13 | Myoscience, Inc. | Cryogenic probe filtration system |
US9241753B2 (en) | 2012-01-13 | 2016-01-26 | Myoscience, Inc. | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
US9254162B2 (en) | 2006-12-21 | 2016-02-09 | Myoscience, Inc. | Dermal and transdermal cryogenic microprobe systems |
US20160058956A1 (en) * | 2014-08-27 | 2016-03-03 | Tva Medical, Inc. | Cryolipolysis devices and methods therefor |
US9295512B2 (en) | 2013-03-15 | 2016-03-29 | Myoscience, Inc. | Methods and devices for pain management |
US9314290B2 (en) | 2012-01-13 | 2016-04-19 | Myoscience, Inc. | Cryogenic needle with freeze zone regulation |
US9381061B2 (en) | 2000-03-06 | 2016-07-05 | Medtronic Advanced Energy Llc | Fluid-assisted medical devices, systems and methods |
US20160262820A1 (en) * | 2015-03-12 | 2016-09-15 | Myoscience, Inc. | Methods and Systems for Preventing Neuroma Formations |
US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
USD777338S1 (en) | 2014-03-20 | 2017-01-24 | Zeltiq Aesthetics, Inc. | Cryotherapy applicator for cooling tissue |
US9592090B2 (en) | 2010-03-11 | 2017-03-14 | Medtronic Advanced Energy Llc | Bipolar electrosurgical cutter with position insensitive return electrode contact |
US9610112B2 (en) | 2013-03-15 | 2017-04-04 | Myoscience, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
US9668800B2 (en) | 2013-03-15 | 2017-06-06 | Myoscience, Inc. | Methods and systems for treatment of spasticity |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
US9861421B2 (en) | 2014-01-31 | 2018-01-09 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
US9956029B2 (en) | 2014-10-31 | 2018-05-01 | Medtronic Advanced Energy Llc | Telescoping device with saline irrigation line |
US9974599B2 (en) | 2014-08-15 | 2018-05-22 | Medtronic Ps Medical, Inc. | Multipurpose electrosurgical device |
US10045817B2 (en) | 2010-11-16 | 2018-08-14 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10130409B2 (en) | 2013-11-05 | 2018-11-20 | Myoscience, Inc. | Secure cryosurgical treatment system |
US10194975B1 (en) | 2017-07-11 | 2019-02-05 | Medtronic Advanced Energy, Llc | Illuminated and isolated electrosurgical apparatus |
US10524956B2 (en) | 2016-01-07 | 2020-01-07 | Zeltiq Aesthetics, Inc. | Temperature-dependent adhesion between applicator and skin during cooling of tissue |
US10543032B2 (en) | 2014-11-13 | 2020-01-28 | Adagio Medical, Inc. | Pressure modulated cryoablation system and related methods |
US10555831B2 (en) | 2016-05-10 | 2020-02-11 | Zeltiq Aesthetics, Inc. | Hydrogel substances and methods of cryotherapy |
US10568759B2 (en) | 2014-08-19 | 2020-02-25 | Zeltiq Aesthetics, Inc. | Treatment systems, small volume applicators, and methods for treating submental tissue |
US10603040B1 (en) | 2015-02-09 | 2020-03-31 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US10617459B2 (en) | 2014-04-17 | 2020-04-14 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter having plurality of preformed treatment shapes |
US10631914B2 (en) | 2013-09-30 | 2020-04-28 | Covidien Lp | Bipolar electrosurgical instrument with movable electrode and related systems and methods |
US10667854B2 (en) | 2013-09-24 | 2020-06-02 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter and related methods |
US10675176B1 (en) | 2014-03-19 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Treatment systems, devices, and methods for cooling targeted tissue |
US10682297B2 (en) | 2016-05-10 | 2020-06-16 | Zeltiq Aesthetics, Inc. | Liposomes, emulsions, and methods for cryotherapy |
US10695534B2 (en) | 2014-03-14 | 2020-06-30 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10716612B2 (en) | 2015-12-18 | 2020-07-21 | Medtronic Advanced Energy Llc | Electrosurgical device with multiple monopolar electrode assembly |
US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
US10765552B2 (en) | 2016-02-18 | 2020-09-08 | Zeltiq Aesthetics, Inc. | Cooling cup applicators with contoured heads and liner assemblies |
US10821217B2 (en) | 2013-03-14 | 2020-11-03 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10864031B2 (en) | 2015-11-30 | 2020-12-15 | Adagio Medical, Inc. | Ablation method for creating elongate continuous lesions enclosing multiple vessel entries |
US10869717B2 (en) | 2012-10-11 | 2020-12-22 | Tva Medical, Inc. | Devices and methods for fistula formation |
US10874422B2 (en) | 2016-01-15 | 2020-12-29 | Tva Medical, Inc. | Systems and methods for increasing blood flow |
US10888366B2 (en) | 2013-03-15 | 2021-01-12 | Pacira Cryotech, Inc. | Cryogenic blunt dissection methods and devices |
US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
US10952891B1 (en) | 2014-05-13 | 2021-03-23 | Zeltiq Aesthetics, Inc. | Treatment systems with adjustable gap applicators and methods for cooling tissue |
US11026743B2 (en) | 2016-01-15 | 2021-06-08 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11051875B2 (en) | 2015-08-24 | 2021-07-06 | Medtronic Advanced Energy Llc | Multipurpose electrosurgical device |
US11051867B2 (en) | 2015-09-18 | 2021-07-06 | Adagio Medical, Inc. | Tissue contact verification system |
US11076879B2 (en) | 2017-04-26 | 2021-08-03 | Zeltiq Aesthetics, Inc. | Shallow surface cryotherapy applicators and related technology |
US11134998B2 (en) | 2017-11-15 | 2021-10-05 | Pacira Cryotech, Inc. | Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods |
US11154418B2 (en) | 2015-10-19 | 2021-10-26 | Zeltiq Aesthetics, Inc. | Vascular treatment systems, cooling devices, and methods for cooling vascular structures |
CN113576648A (en) * | 2021-06-30 | 2021-11-02 | 海杰亚(北京)医疗器械有限公司 | Ablation device |
US11285028B2 (en) | 2016-09-25 | 2022-03-29 | Tva Medical, Inc. | Vascular stent devices and methods |
US11311327B2 (en) | 2016-05-13 | 2022-04-26 | Pacira Cryotech, Inc. | Methods and systems for locating and treating nerves with cold therapy |
US11382790B2 (en) | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
US11389227B2 (en) | 2015-08-20 | 2022-07-19 | Medtronic Advanced Energy Llc | Electrosurgical device with multivariate control |
US11446175B2 (en) | 2018-07-31 | 2022-09-20 | Zeltiq Aesthetics, Inc. | Methods, devices, and systems for improving skin characteristics |
US11564725B2 (en) | 2017-09-05 | 2023-01-31 | Adagio Medical, Inc. | Ablation catheter having a shape memory stylet |
US11590322B2 (en) | 2016-01-15 | 2023-02-28 | Tva Medical, Inc. | Devices and methods for advancing a wire |
US11633224B2 (en) | 2020-02-10 | 2023-04-25 | Icecure Medical Ltd. | Cryogen pump |
US11751930B2 (en) | 2018-01-10 | 2023-09-12 | Adagio Medical, Inc. | Cryoablation element with conductive liner |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE216856C (en) * | 1909-03-26 | 1909-12-04 | Bbc Brown Boveri & Cie | Fastening of the disk wheels of steam or gas turbines on the shaft or drum |
US3434477A (en) * | 1966-11-23 | 1969-03-25 | Univ Northwestern | Surgical instrument |
US3608539A (en) * | 1968-11-06 | 1971-09-28 | Daniel G Miller | Method for the biopsy of subcutaneous masses |
US3712306A (en) * | 1971-11-09 | 1973-01-23 | Brymill Corp | Cryogenic application chamber and method |
US3889618A (en) * | 1974-06-26 | 1975-06-17 | Clark Equipment Co | Rolling apparatus |
US4275734A (en) * | 1977-08-12 | 1981-06-30 | Valleylab, Inc. | Cryosurgical apparatus and method |
US4306568A (en) * | 1979-12-04 | 1981-12-22 | Torre Douglas P | Method and apparatus for congelation cryometry in cryosurgery |
SU906553A1 (en) * | 1980-04-29 | 1982-02-23 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Cryoapplicator |
SU1168224A1 (en) * | 1983-04-07 | 1985-07-23 | Киевский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.Акад.А.А.Богомольца | Needle for puncture of ethmoidal labyrinth |
-
1987
- 1987-06-22 US US07/064,619 patent/US4802475A/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE216856C (en) * | 1909-03-26 | 1909-12-04 | Bbc Brown Boveri & Cie | Fastening of the disk wheels of steam or gas turbines on the shaft or drum |
US3434477A (en) * | 1966-11-23 | 1969-03-25 | Univ Northwestern | Surgical instrument |
US3608539A (en) * | 1968-11-06 | 1971-09-28 | Daniel G Miller | Method for the biopsy of subcutaneous masses |
US3712306A (en) * | 1971-11-09 | 1973-01-23 | Brymill Corp | Cryogenic application chamber and method |
US3889618A (en) * | 1974-06-26 | 1975-06-17 | Clark Equipment Co | Rolling apparatus |
US4275734A (en) * | 1977-08-12 | 1981-06-30 | Valleylab, Inc. | Cryosurgical apparatus and method |
US4306568A (en) * | 1979-12-04 | 1981-12-22 | Torre Douglas P | Method and apparatus for congelation cryometry in cryosurgery |
SU906553A1 (en) * | 1980-04-29 | 1982-02-23 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Cryoapplicator |
SU1168224A1 (en) * | 1983-04-07 | 1985-07-23 | Киевский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.Акад.А.А.Богомольца | Needle for puncture of ethmoidal labyrinth |
Cited By (459)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200170A (en) * | 1989-07-18 | 1993-04-06 | Mcdow Ronald A | Medical process--use of dichlorodifluoromethane (CCl2 F2) and chlorodifluoromethane (CHClF2) as cryogens for treating skin lesions |
US6161543A (en) * | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US5571147A (en) * | 1993-11-02 | 1996-11-05 | Sluijter; Menno E. | Thermal denervation of an intervertebral disc for relief of back pain |
US5647868A (en) * | 1994-02-02 | 1997-07-15 | Chinn; Douglas Owen | Cryosurgical integrated control and monitoring system and method |
WO1995030380A2 (en) * | 1994-05-10 | 1995-11-16 | Spembly Medical Limited | Cryosurgical instrument |
WO1995030380A3 (en) * | 1994-05-10 | 1996-05-02 | Spembly Medical Ltd | Cryosurgical instrument |
US5860970A (en) * | 1994-05-10 | 1999-01-19 | Spembly Medical Limited | Cryosurgical instrument |
US9770282B2 (en) | 1995-02-22 | 2017-09-26 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US7422588B2 (en) | 1995-02-22 | 2008-09-09 | Medtronic, Inc. | Pen-type electrosurgical instrument |
US20070208332A1 (en) * | 1995-02-22 | 2007-09-06 | Mulier Peter M | Pen-type electrosurgical instrument |
US7247155B2 (en) | 1995-02-22 | 2007-07-24 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US7794460B2 (en) | 1995-02-22 | 2010-09-14 | Medtronic, Inc. | Method of ablating tissue |
US20040215183A1 (en) * | 1995-02-22 | 2004-10-28 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US7166105B2 (en) | 1995-02-22 | 2007-01-23 | Medtronic, Inc. | Pen-type electrosurgical instrument |
EP0833590A1 (en) * | 1995-04-28 | 1998-04-08 | Douglas O. Chinn | Cryosurgical integrated control monitoring system and method |
WO1996037158A1 (en) * | 1995-04-28 | 1996-11-28 | Chinn Douglas O | Cryosurgical integrated control monitoring system and method |
EP0833590A4 (en) * | 1995-04-28 | 2000-05-31 | Douglas O Chinn | Cryosurgical integrated control monitoring system and method |
AU707710B2 (en) * | 1995-04-28 | 1999-07-15 | Douglas O. Chinn | Cryosurgical integrated control monitoring system and method |
US5733280A (en) * | 1995-11-15 | 1998-03-31 | Avitall; Boaz | Cryogenic epicardial mapping and ablation |
US20030191462A1 (en) * | 1996-05-03 | 2003-10-09 | Jacobs Clemens J. | Method for interrupting conduction paths within the heart |
US7128740B2 (en) | 1996-05-03 | 2006-10-31 | Jacobs Clemens J | Method for interrupting conduction paths within the heart |
US8002771B2 (en) | 1996-10-22 | 2011-08-23 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US6840936B2 (en) | 1996-10-22 | 2005-01-11 | Epicor Medical, Inc. | Methods and devices for ablation |
US20060004352A1 (en) * | 1996-10-22 | 2006-01-05 | Matthias Vaska | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6474340B1 (en) | 1996-10-22 | 2002-11-05 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US20020173784A1 (en) * | 1996-10-22 | 2002-11-21 | Epicor, Inc. | Methods and devices for ablation |
US6484727B1 (en) | 1996-10-22 | 2002-11-26 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US7824403B2 (en) | 1996-10-22 | 2010-11-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US6971394B2 (en) | 1996-10-22 | 2005-12-06 | Epicor Medical, Inc. | Methods and devices for ablation |
US8535301B2 (en) | 1996-10-22 | 2013-09-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US20030079753A1 (en) * | 1996-10-22 | 2003-05-01 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
WO1998017187A1 (en) * | 1996-10-22 | 1998-04-30 | Heartport, Inc. | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US6645202B1 (en) | 1996-10-22 | 2003-11-11 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US20050245918A1 (en) * | 1996-10-22 | 2005-11-03 | Sliwa John W Jr | Methods and devices for ablation |
US7674257B2 (en) | 1996-10-22 | 2010-03-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US20070255276A1 (en) * | 1996-10-22 | 2007-11-01 | St. Jude Medical, Atrial Fibrillation Division | Methods and devices for ablation |
US6689128B2 (en) | 1996-10-22 | 2004-02-10 | Epicor Medical, Inc. | Methods and devices for ablation |
US6701931B2 (en) | 1996-10-22 | 2004-03-09 | Epicor Medical, Inc. | Methods and devices for ablation |
US6949095B2 (en) | 1996-10-22 | 2005-09-27 | Epicor Medical, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6719755B2 (en) | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US8721636B2 (en) | 1996-10-22 | 2014-05-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US20060135954A1 (en) * | 1996-10-22 | 2006-06-22 | Epicor Medical, Inc. A Delaware Corporation. | Methods and devices for ablation |
US20070191714A1 (en) * | 1996-10-22 | 2007-08-16 | Cox James L | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US7338486B2 (en) | 1996-10-22 | 2008-03-04 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US6314963B1 (en) | 1996-10-22 | 2001-11-13 | Epicor, Inc. | Method of ablating tissue from an epicardial location |
US20060184167A1 (en) * | 1996-10-22 | 2006-08-17 | Matthias Vaska | Methods and devices for ablation |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6805129B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6237605B1 (en) | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6314962B1 (en) | 1996-10-22 | 2001-11-13 | Epicor, Inc. | Method of ablating tissue around the pulmonary veins |
US6858026B2 (en) | 1996-10-22 | 2005-02-22 | Epicor Medical, Inc. | Methods and devices for ablation |
US7387126B2 (en) | 1996-10-22 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Surgical system and procedure for treatment of medically refractory atrial fibrillation |
US8114069B2 (en) | 1996-10-22 | 2012-02-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US20050033274A1 (en) * | 1996-10-22 | 2005-02-10 | Epicor Medical, Inc., A Delaware Corporation | Apparatus and method for ablating tissue |
US8057465B2 (en) | 1996-10-22 | 2011-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US5976505A (en) * | 1997-07-02 | 1999-11-02 | Hcs Trust | Method for cryogenically treating psoriasis with liquid nitrogen or liquid nitrous oxide |
US20060079888A1 (en) * | 1997-07-18 | 2006-04-13 | Mulier Peter M J | Device and method for ablating tissue |
US20040236322A1 (en) * | 1997-07-18 | 2004-11-25 | Mulier Peter M.J. | Device and method for ablating tissue |
US7678111B2 (en) | 1997-07-18 | 2010-03-16 | Medtronic, Inc. | Device and method for ablating tissue |
US7470272B2 (en) | 1997-07-18 | 2008-12-30 | Medtronic, Inc. | Device and method for ablating tissue |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US20040087941A1 (en) * | 1998-05-20 | 2004-05-06 | Wang Paul J. | Cardiac system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US20060217699A1 (en) * | 1998-05-20 | 2006-09-28 | Wang Paul J | Cardiac ablation system and method for treatment of cardiac arrhthmias and transmyocardial revascularization |
US7041095B2 (en) | 1998-05-20 | 2006-05-09 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6401722B1 (en) * | 1998-06-12 | 2002-06-11 | Calypso Medical Technologies, Inc. | Method for stabilizing and removing tissue |
US6241722B1 (en) | 1998-06-17 | 2001-06-05 | Cryogen, Inc. | Cryogenic device, system and method of using same |
US7699805B2 (en) | 1998-07-07 | 2010-04-20 | Medtronic, Inc. | Helical coil apparatus for ablation of tissue |
US7309325B2 (en) | 1998-07-07 | 2007-12-18 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US20070093808A1 (en) * | 1998-07-07 | 2007-04-26 | Mulier Peter M J | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US7169144B2 (en) | 1998-07-07 | 2007-01-30 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US20060009760A1 (en) * | 1998-07-07 | 2006-01-12 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US7156845B2 (en) | 1998-07-07 | 2007-01-02 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US9113896B2 (en) | 1998-07-07 | 2015-08-25 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US20080091194A1 (en) * | 1998-07-07 | 2008-04-17 | Mulier Peter M | Helical coil apparatus for ablation of tissue |
US20060052770A1 (en) * | 1998-07-07 | 2006-03-09 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US20050251125A1 (en) * | 1998-09-21 | 2005-11-10 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US20080091195A1 (en) * | 1998-09-21 | 2008-04-17 | Sliwa John W | Apparatus and method for ablating tissue |
US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US20070282324A1 (en) * | 1999-07-19 | 2007-12-06 | Matthias Vaska | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US9055959B2 (en) | 1999-07-19 | 2015-06-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and devices for ablation |
US20080045936A1 (en) * | 1999-07-19 | 2008-02-21 | Matthias Vaska | Methods and devices for ablation |
WO2001041683A3 (en) * | 1999-12-07 | 2002-03-28 | Dieter Steinfatt | Applicator for the application of cryogenic refrigerants and application device |
WO2001041683A2 (en) * | 1999-12-07 | 2001-06-14 | Dieter Steinfatt | Applicator for the application of cryogenic refrigerants and application device |
US20040015106A1 (en) * | 2000-01-19 | 2004-01-22 | Coleman R. Glen | Focused ultrasound ablation devices having selectively actuatable emitting elements and methods of using the same |
US20050267454A1 (en) * | 2000-01-19 | 2005-12-01 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US7615015B2 (en) | 2000-01-19 | 2009-11-10 | Medtronic, Inc. | Focused ultrasound ablation devices having selectively actuatable emitting elements and methods of using the same |
US7706882B2 (en) | 2000-01-19 | 2010-04-27 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US8221402B2 (en) | 2000-01-19 | 2012-07-17 | Medtronic, Inc. | Method for guiding a medical device |
US20060025756A1 (en) * | 2000-01-19 | 2006-02-02 | Francischelli David E | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US20060229594A1 (en) * | 2000-01-19 | 2006-10-12 | Medtronic, Inc. | Method for guiding a medical device |
US9381061B2 (en) | 2000-03-06 | 2016-07-05 | Medtronic Advanced Energy Llc | Fluid-assisted medical devices, systems and methods |
US8568409B2 (en) | 2000-03-06 | 2013-10-29 | Medtronic Advanced Energy Llc | Fluid-assisted medical devices, systems and methods |
US20070049920A1 (en) * | 2000-03-06 | 2007-03-01 | Tissuelink Medical, Inc. | Fluid-Assisted Medical Devices, Fluid Delivery Systems and Controllers for Such Devices, and Methods |
US6896673B2 (en) | 2000-04-27 | 2005-05-24 | Atricure, Inc. | Method for transmural ablation |
US20050033283A1 (en) * | 2000-04-27 | 2005-02-10 | Hooven Michael D. | Sub-xyphoid method for ablating cardiac tissue |
US20020107513A1 (en) * | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with thin electrodes |
US6517536B2 (en) | 2000-04-27 | 2003-02-11 | Atricure, Inc. | Transmural ablation device and method |
US6932811B2 (en) | 2000-04-27 | 2005-08-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
US20050171530A1 (en) * | 2000-04-27 | 2005-08-04 | Hooven Michael D. | Transmural ablation device |
US7487780B2 (en) | 2000-04-27 | 2009-02-10 | Atricure, Inc. | Sub-xyphoid method for ablating cardiac tissue |
US6923806B2 (en) | 2000-04-27 | 2005-08-02 | Atricure Inc. | Transmural ablation device with spring loaded jaws |
US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US7468061B2 (en) | 2000-04-27 | 2008-12-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
US7435250B2 (en) | 2000-04-27 | 2008-10-14 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US7543589B2 (en) | 2000-04-27 | 2009-06-09 | Atricure, Inc. | Method for ablating cardiac tissue |
US7113831B2 (en) | 2000-04-27 | 2006-09-26 | Atricure, Inc. | Transmural ablation device |
US6905498B2 (en) | 2000-04-27 | 2005-06-14 | Atricure Inc. | Transmural ablation device with EKG sensor and pacing electrode |
US6899710B2 (en) | 2000-04-27 | 2005-05-31 | Atricure Inc. | Combination ablation and visualization apparatus for ablating cardiac tissue |
US7818039B2 (en) | 2000-04-27 | 2010-10-19 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US7393353B2 (en) | 2000-04-27 | 2008-07-01 | Atricure, Inc. | Transmural ablation device with temperature sensor |
US9693819B2 (en) | 2000-04-27 | 2017-07-04 | Medtronic, Inc. | Vibration sensitive ablation device and method |
US6984233B2 (en) | 2000-04-27 | 2006-01-10 | Atricure, Inc. | Transmural ablation device with parallel electrodes |
US6889694B2 (en) | 2000-04-27 | 2005-05-10 | Atricure Inc. | Transmural ablation device |
US20050033284A1 (en) * | 2000-04-27 | 2005-02-10 | Hooven Michael D. | Transmural ablation device with integral EKG sensor |
US6974454B2 (en) | 2000-04-27 | 2005-12-13 | Atricure, Inc. | Transmural ablation device with thermocouple for measuring tissue temperature |
US20050033282A1 (en) * | 2000-04-27 | 2005-02-10 | Hooven Michael D. | Transmural ablation device with parallel electrodes |
US20050021024A1 (en) * | 2000-04-27 | 2005-01-27 | Hooven Michael D. | Transmural ablation device with temperature sensor |
US7001415B2 (en) | 2000-04-27 | 2006-02-21 | Atricure, Inc. | Transmural ablation device |
US8162933B2 (en) | 2000-04-27 | 2012-04-24 | Medtronic, Inc. | Vibration sensitive ablation device and method |
US20110066146A1 (en) * | 2000-04-27 | 2011-03-17 | Jahns Scott E | Suction Stabilized Epicardial Ablation Devices |
US20040138656A1 (en) * | 2000-04-27 | 2004-07-15 | Francischelli David E. | System and method for assessing transmurality of ablation lesions |
US7241292B2 (en) | 2000-04-27 | 2007-07-10 | Atricure, Inc. | Cardiac ablation device with movable hinge |
US20070118107A1 (en) * | 2000-04-27 | 2007-05-24 | Francischelli David E | Vibration sensitive ablation device and method |
US7604634B2 (en) | 2000-04-27 | 2009-10-20 | Atricure, Inc. | Transmural ablation device |
US20070135811A1 (en) * | 2000-04-27 | 2007-06-14 | Hooven Michael D | Method for ablating cardiac tissue |
US6503246B1 (en) * | 2000-07-05 | 2003-01-07 | Mor Research Applications Ltd. | Cryoprobe and method of treating scars |
US7706894B2 (en) | 2000-10-10 | 2010-04-27 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US20100168740A1 (en) * | 2000-10-10 | 2010-07-01 | Medtronic, Inc. | Heart Wall Ablation/Mapping Catheter and Method |
US8706260B2 (en) | 2000-10-10 | 2014-04-22 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US20050273006A1 (en) * | 2000-10-10 | 2005-12-08 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US7740623B2 (en) | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US7507235B2 (en) | 2001-01-13 | 2009-03-24 | Medtronic, Inc. | Method and system for organ positioning and stabilization |
US7628780B2 (en) | 2001-01-13 | 2009-12-08 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20090143638A1 (en) * | 2001-01-13 | 2009-06-04 | Medtronic, Inc. | Method and System for Organ Positioning and Stabilization |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20020138109A1 (en) * | 2001-01-13 | 2002-09-26 | Medtronic, Inc. | Method and system for organ positioning and stabilization |
US20050209564A1 (en) * | 2001-01-13 | 2005-09-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US8262649B2 (en) | 2001-04-26 | 2012-09-11 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US8512337B2 (en) | 2001-04-26 | 2013-08-20 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US20040049179A1 (en) * | 2001-04-26 | 2004-03-11 | Francischelli David E. | Ablation system |
US20070270799A1 (en) * | 2001-04-26 | 2007-11-22 | Francischelli David E | Method and apparatus for tissue ablation |
US7094235B2 (en) | 2001-04-26 | 2006-08-22 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US6761715B2 (en) | 2001-04-26 | 2004-07-13 | Ronald J. Carroll | Method and device for neurocryo analgesia and anesthesia |
US20040143260A1 (en) * | 2001-04-26 | 2004-07-22 | Francischelli David E. | Method and apparatus for tissue ablation |
US7250048B2 (en) | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US20080015562A1 (en) * | 2001-04-26 | 2008-01-17 | Medtronic, Inc. | Transmural ablation systems and methods |
US7367972B2 (en) | 2001-04-26 | 2008-05-06 | Medtronic, Inc. | Ablation system |
US7959626B2 (en) | 2001-04-26 | 2011-06-14 | Medtronic, Inc. | Transmural ablation systems and methods |
US7250051B2 (en) | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US20080071271A1 (en) * | 2001-04-26 | 2008-03-20 | Francischelli David E | Method and apparatus for tissue ablation |
US20060195082A1 (en) * | 2001-04-26 | 2006-08-31 | Francischelli David E | Method and apparatus for tissue ablation |
US7824399B2 (en) | 2001-04-26 | 2010-11-02 | Medtronic, Inc. | Ablation system and method of use |
US8221415B2 (en) | 2001-04-26 | 2012-07-17 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US7347858B2 (en) | 2001-12-11 | 2008-03-25 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US20040078069A1 (en) * | 2001-12-11 | 2004-04-22 | Francischelli David E. | Method and system for treatment of atrial tachyarrhythmias |
US20090326527A1 (en) * | 2002-01-25 | 2009-12-31 | Ocel Jon M | Cardiac Mapping Instrument with Shapeable Electrode |
US8623010B2 (en) | 2002-01-25 | 2014-01-07 | Medtronic, Inc. | Cardiac mapping instrument with shapeable electrode |
US7364578B2 (en) | 2002-01-25 | 2008-04-29 | Medtronic, Inc. | System and method of performing an electrosurgical procedure |
US20050165392A1 (en) * | 2002-01-25 | 2005-07-28 | Medtronic, Inc. | System and method of performing an electrosurgical procedure |
US20040267326A1 (en) * | 2002-01-25 | 2004-12-30 | Ocel Jon M | Cardiac mapping instrument with shapeable electrode |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US20070043397A1 (en) * | 2002-01-25 | 2007-02-22 | Ocel Jon M | Cardiac mapping instrument with shapeable electrode |
US20080275439A1 (en) * | 2002-01-25 | 2008-11-06 | David Francischelli | Cardiac ablation and electrical interface system and instrument |
US9649220B2 (en) | 2002-03-15 | 2017-05-16 | The General Hospital Corporation | Treatment systems for removing heat from subcutaneous lipid-rich cells |
US9358149B2 (en) | 2002-03-15 | 2016-06-07 | The General Hospital Corporation | Systems for affecting subcutaneous lipid-rich cells, systems for removing heat from subcutaneous lipid-rich cells, and systems for reducing subcutaneous lipid-rich cells |
US20030220674A1 (en) * | 2002-03-15 | 2003-11-27 | Anderson Richard Rox | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US11590020B2 (en) | 2002-03-15 | 2023-02-28 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US7367341B2 (en) | 2002-03-15 | 2008-05-06 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US8840608B2 (en) | 2002-03-15 | 2014-09-23 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US9308120B2 (en) | 2002-03-15 | 2016-04-12 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US20070010861A1 (en) * | 2002-03-15 | 2007-01-11 | Anderson Richard R | Methods and devices for selective disruption of fatty tissue by controlled cooling |
US20050251120A1 (en) * | 2002-03-15 | 2005-11-10 | Anderson Richard R | Methods and devices for detection and control of selective disruption of fatty tissue during controlled cooling |
US8834547B2 (en) | 2002-03-15 | 2014-09-16 | The General Hospital Corporation | Treatment systems for removing heat from subcutaneous lipid-rich cells |
US20070032786A1 (en) * | 2002-05-16 | 2007-02-08 | Francischelli David E | Device and method for ablation of cardiac tissue |
US8414573B2 (en) | 2002-05-16 | 2013-04-09 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
US7294143B2 (en) | 2002-05-16 | 2007-11-13 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
US20070049923A1 (en) * | 2002-05-16 | 2007-03-01 | Jahns Scott E | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US7975703B2 (en) | 2002-05-16 | 2011-07-12 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US20040015219A1 (en) * | 2002-05-16 | 2004-01-22 | Francischelli David E. | Device and method for ablation of cardiac tissue |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US20050149064A1 (en) * | 2002-06-25 | 2005-07-07 | Peterson James A. | Method and apparatus for tissue fastening with single translating trigger operation |
US7291161B2 (en) | 2002-10-02 | 2007-11-06 | Atricure, Inc. | Articulated clamping member |
US7083620B2 (en) | 2002-10-30 | 2006-08-01 | Medtronic, Inc. | Electrosurgical hemostat |
US20060041254A1 (en) * | 2002-10-30 | 2006-02-23 | Medtronic, Inc. | Electrosurgical hemostat |
US20060195083A1 (en) * | 2002-10-30 | 2006-08-31 | Jahns Scott E | Electrosurgical hemostat |
US7963963B2 (en) | 2002-10-30 | 2011-06-21 | Medtronic, Inc. | Electrosurgical hemostat |
US20040138621A1 (en) * | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US7744562B2 (en) | 2003-01-14 | 2010-06-29 | Medtronics, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US8273072B2 (en) | 2003-01-14 | 2012-09-25 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20060235375A1 (en) * | 2003-01-15 | 2006-10-19 | Cryodynamics, Llc | Cryotherapy system |
US7507233B2 (en) | 2003-01-15 | 2009-03-24 | Cryo Dynamics, Llc | Cryotherapy system |
US20110162390A1 (en) * | 2003-01-15 | 2011-07-07 | Littrup Peter J | Methods and systems for cryogenic cooling |
US20080119836A1 (en) * | 2003-01-15 | 2008-05-22 | Cryodynamics, Llc | Cryotherapy probe |
US7083612B2 (en) | 2003-01-15 | 2006-08-01 | Cryodynamics, Llc | Cryotherapy system |
US9408656B2 (en) | 2003-01-15 | 2016-08-09 | Adagio Medical, Inc. | Cryotherapy probe |
US20040215294A1 (en) * | 2003-01-15 | 2004-10-28 | Mediphysics Llp | Cryotherapy probe |
US20080173028A1 (en) * | 2003-01-15 | 2008-07-24 | Cryodynamics, Llc | Methods and systems for cryogenic cooling |
US8591503B2 (en) | 2003-01-15 | 2013-11-26 | Cryodynamics, Llc | Cryotherapy probe |
US8387402B2 (en) | 2003-01-15 | 2013-03-05 | Cryodynamics, Llc | Methods and systems for cryogenic cooling |
US7273479B2 (en) | 2003-01-15 | 2007-09-25 | Cryodynamics, Llc | Methods and systems for cryogenic cooling |
US7921657B2 (en) | 2003-01-15 | 2011-04-12 | Endocare, Inc. | Methods and systems for cryogenic cooling |
US7410484B2 (en) | 2003-01-15 | 2008-08-12 | Cryodynamics, Llc | Cryotherapy probe |
US7288092B2 (en) | 2003-04-23 | 2007-10-30 | Atricure, Inc. | Method and apparatus for ablating cardiac tissue with guide facility |
US20080215042A1 (en) * | 2003-04-24 | 2008-09-04 | Swanson David K | Therapeutic Apparatus Having Insulated Region At The Insertion Area |
US7306590B2 (en) | 2003-04-24 | 2007-12-11 | Boston Scientific Scimed, Inc. | Therapeutic apparatus having insulated region at the insertion area |
US20060089630A1 (en) * | 2003-04-24 | 2006-04-27 | Swanson David K | Therapeutic apparatus having insulated region at the insertion area |
US20060089631A1 (en) * | 2003-04-24 | 2006-04-27 | Swanson David K | Therapeutic apparatus having insulated region at the insertion area |
US7306589B2 (en) | 2003-04-24 | 2007-12-11 | Boston Scientific Scimed, Inc. | Therapeutic apparatus having insulated region at the insertion area |
US8535305B2 (en) | 2003-04-24 | 2013-09-17 | Boston Scientific Scimed, Inc. | Therapeutic apparatus having insulated region at the insertion area |
US8870859B2 (en) | 2003-04-24 | 2014-10-28 | Boston Scientific Scimed, Inc. | Therapeutic apparatus having insulated region at the insertion area |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US7871409B2 (en) | 2003-04-29 | 2011-01-18 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US20040220560A1 (en) * | 2003-04-29 | 2004-11-04 | Briscoe Roderick E. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US20090138008A1 (en) * | 2003-04-29 | 2009-05-28 | Medtronic, Inc. | Endocardial Dispersive Electrode for Use with a Monopolar RF Ablation Pen |
US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
US20050234444A1 (en) * | 2004-04-14 | 2005-10-20 | Hooven Michael D | Electrode and bipolar ablation method using same |
US7530980B2 (en) | 2004-04-14 | 2009-05-12 | Atricure, Inc | Bipolar transmural ablation method and apparatus |
US20050256522A1 (en) * | 2004-05-12 | 2005-11-17 | Medtronic, Inc. | Device and method for determining tissue thickness and creating cardiac ablation lesions |
US8333764B2 (en) | 2004-05-12 | 2012-12-18 | Medtronic, Inc. | Device and method for determining tissue thickness and creating cardiac ablation lesions |
US8801707B2 (en) | 2004-05-14 | 2014-08-12 | Medtronic, Inc. | Method and devices for treating atrial fibrillation by mass ablation |
US20060009756A1 (en) * | 2004-05-14 | 2006-01-12 | Francischelli David E | Method and devices for treating atrial fibrillation by mass ablation |
US7875028B2 (en) | 2004-06-02 | 2011-01-25 | Medtronic, Inc. | Ablation device with jaws |
US20110071519A1 (en) * | 2004-06-02 | 2011-03-24 | Rothstein Paul T | Clamping Ablation Tool and Method |
US20060047278A1 (en) * | 2004-06-02 | 2006-03-02 | Christian Steven C | Ablation device with jaws |
US20060020263A1 (en) * | 2004-06-02 | 2006-01-26 | Rothstein Paul T | Clamping ablation tool and method |
US7566334B2 (en) | 2004-06-02 | 2009-07-28 | Medtronic, Inc. | Ablation device with jaws |
US20110087205A1 (en) * | 2004-06-02 | 2011-04-14 | Christian Steven C | Ablation device with jaws |
US20060009759A1 (en) * | 2004-06-02 | 2006-01-12 | Chrisitian Steven C | Loop ablation apparatus and method |
US20060036236A1 (en) * | 2004-06-02 | 2006-02-16 | Rothstein Paul T | Compound bipolar ablation device and method |
US7758580B2 (en) | 2004-06-02 | 2010-07-20 | Medtronic, Inc. | Compound bipolar ablation device and method |
US8172837B2 (en) | 2004-06-02 | 2012-05-08 | Medtronic, Inc. | Clamping ablation tool and method |
US8162941B2 (en) | 2004-06-02 | 2012-04-24 | Medtronic, Inc. | Ablation device with jaws |
US20090270857A1 (en) * | 2004-06-02 | 2009-10-29 | Christian Steven C | Ablation Device with Jaws |
US7758576B2 (en) | 2004-06-02 | 2010-07-20 | Medtronic, Inc. | Clamping ablation tool and method |
US7678108B2 (en) | 2004-06-02 | 2010-03-16 | Medtronic, Inc. | Loop ablation apparatus and method |
US20100145361A1 (en) * | 2004-06-18 | 2010-06-10 | Francischelli David E | Methods and Devices for Occlusion of an Atrial Appendage |
US8409219B2 (en) | 2004-06-18 | 2013-04-02 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
US20100042110A1 (en) * | 2004-06-18 | 2010-02-18 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
US8663245B2 (en) | 2004-06-18 | 2014-03-04 | Medtronic, Inc. | Device for occlusion of a left atrial appendage |
US8926635B2 (en) | 2004-06-18 | 2015-01-06 | Medtronic, Inc. | Methods and devices for occlusion of an atrial appendage |
US20060020271A1 (en) * | 2004-06-18 | 2006-01-26 | Stewart Mark T | Methods and devices for occlusion of an atrial appendage |
US9656063B2 (en) | 2004-06-18 | 2017-05-23 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
US7862558B2 (en) | 2005-05-20 | 2011-01-04 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US9345526B2 (en) | 2005-05-20 | 2016-05-24 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US7713266B2 (en) | 2005-05-20 | 2010-05-11 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20090171334A1 (en) * | 2005-05-20 | 2009-07-02 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US11350979B2 (en) | 2005-05-20 | 2022-06-07 | Pacira Cryotech, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US7850683B2 (en) | 2005-05-20 | 2010-12-14 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20110144631A1 (en) * | 2005-05-20 | 2011-06-16 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20100198207A1 (en) * | 2005-05-20 | 2010-08-05 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US9072498B2 (en) * | 2005-05-20 | 2015-07-07 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US10363080B2 (en) | 2005-05-20 | 2019-07-30 | Pacira Cryotech, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20080183164A1 (en) * | 2005-05-20 | 2008-07-31 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20070129714A1 (en) * | 2005-05-20 | 2007-06-07 | Echo Healthcare Llc | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (FAT) |
US7998137B2 (en) | 2005-05-20 | 2011-08-16 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US20060270900A1 (en) * | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US7625368B2 (en) * | 2005-10-17 | 2009-12-01 | Galil Medical Ltd. | Endometrial ablation device and method |
US20070088344A1 (en) * | 2005-10-17 | 2007-04-19 | Galil Medical Ltd. | Endometrial ablation device and method |
US20070198071A1 (en) * | 2006-02-22 | 2007-08-23 | Juniper Medical Systems | Cooling device for removing heat from subcutaneous lipid-rich cells |
US7854754B2 (en) | 2006-02-22 | 2010-12-21 | Zeltiq Aesthetics, Inc. | Cooling device for removing heat from subcutaneous lipid-rich cells |
US8337539B2 (en) | 2006-02-22 | 2012-12-25 | Zeltiq Aesthetics, Inc. | Cooling device for removing heat from subcutaneous lipid-rich cells |
US20070213705A1 (en) * | 2006-03-08 | 2007-09-13 | Schmid Peter M | Insulated needle and system |
US20070225697A1 (en) * | 2006-03-23 | 2007-09-27 | Ketan Shroff | Apparatus and methods for cardiac ablation |
US20090299357A1 (en) * | 2006-04-24 | 2009-12-03 | Thomas Jefferson University | Cryoneedle and cryotheraphy system |
US20070255362A1 (en) * | 2006-04-28 | 2007-11-01 | Juniper Medical, Inc. | Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells |
US20100217162A1 (en) * | 2006-05-25 | 2010-08-26 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US9227088B2 (en) | 2006-05-25 | 2016-01-05 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US9724119B2 (en) | 2006-05-25 | 2017-08-08 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US20080039746A1 (en) * | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US9931134B2 (en) | 2006-05-25 | 2018-04-03 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US10589130B2 (en) | 2006-05-25 | 2020-03-17 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US20080140061A1 (en) * | 2006-09-08 | 2008-06-12 | Arbel Medical Ltd. | Method And Device For Combined Treatment |
US11179269B2 (en) | 2006-09-26 | 2021-11-23 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US8192474B2 (en) | 2006-09-26 | 2012-06-05 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
US11395760B2 (en) | 2006-09-26 | 2022-07-26 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
US11219549B2 (en) | 2006-09-26 | 2022-01-11 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US9375345B2 (en) | 2006-09-26 | 2016-06-28 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20080077211A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US10292859B2 (en) | 2006-09-26 | 2019-05-21 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20080077202A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Tissue Treatment Methods |
US20080077201A1 (en) * | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling devices with flexible sensors |
US20080110182A1 (en) * | 2006-11-10 | 2008-05-15 | Vancelette David W | Coaxial Cryogenic Refrigeration Coupler |
US20080119838A1 (en) * | 2006-11-17 | 2008-05-22 | Vancelette David W | Disposable Sheath with Replaceable Console Probes for Cryosurgery |
US8298221B2 (en) | 2006-11-17 | 2012-10-30 | Coopersurgical, Inc. | Disposable sheath with replaceable console probes for cryosurgery |
US10939947B2 (en) | 2006-12-21 | 2021-03-09 | Pacira Cryotech, Inc. | Dermal and transdermal cryogenic microprobe systems |
US9254162B2 (en) | 2006-12-21 | 2016-02-09 | Myoscience, Inc. | Dermal and transdermal cryogenic microprobe systems |
US20080208181A1 (en) * | 2007-01-19 | 2008-08-28 | Arbel Medical Ltd. | Thermally Insulated Needles For Dermatological Applications |
US9113855B2 (en) | 2007-02-16 | 2015-08-25 | Myoscience, Inc. | Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling |
US8409185B2 (en) | 2007-02-16 | 2013-04-02 | Myoscience, Inc. | Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling |
US11291606B2 (en) | 2007-05-18 | 2022-04-05 | Zeltiq Aesthetics, Inc. | Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue |
US10383787B2 (en) | 2007-05-18 | 2019-08-20 | Zeltiq Aesthetics, Inc. | Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue |
US20080287839A1 (en) * | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
US20100162730A1 (en) * | 2007-06-14 | 2010-07-01 | Arbel Medical Ltd. | Siphon for delivery of liquid cryogen from dewar flask |
US20100324546A1 (en) * | 2007-07-09 | 2010-12-23 | Alexander Levin | Cryosheath |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
US20090018626A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | User interfaces for a system that removes heat from lipid-rich regions |
US9655770B2 (en) | 2007-07-13 | 2017-05-23 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
US20090018625A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Managing system temperature to remove heat from lipid-rich regions |
US20090018624A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Limiting use of disposable system patient protection devices |
US20090018623A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | System for treating lipid-rich regions |
US10675178B2 (en) | 2007-08-21 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US11583438B1 (en) | 2007-08-21 | 2023-02-21 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US8285390B2 (en) | 2007-08-21 | 2012-10-09 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US9408745B2 (en) | 2007-08-21 | 2016-08-09 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US20090062737A1 (en) * | 2007-08-28 | 2009-03-05 | Sun William Y | Ice coated hypodermic needle |
US20090093809A1 (en) * | 2007-10-05 | 2009-04-09 | Anderson Evan R | Devices and methods for minimally-invasive surgical procedures |
US10993766B2 (en) | 2007-10-05 | 2021-05-04 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US10058380B2 (en) | 2007-10-05 | 2018-08-28 | Maquet Cordiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US9101346B2 (en) | 2007-11-14 | 2015-08-11 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US8715275B2 (en) | 2007-11-14 | 2014-05-06 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US8298216B2 (en) | 2007-11-14 | 2012-10-30 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US9907693B2 (en) | 2007-11-14 | 2018-03-06 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US10869779B2 (en) | 2007-11-14 | 2020-12-22 | Pacira Cryotech, Inc. | Pain management using cryogenic remodeling |
US10864112B2 (en) | 2007-11-14 | 2020-12-15 | Pacira Cryotech, Inc. | Pain management using cryogenic remodeling |
US11672694B2 (en) | 2007-11-14 | 2023-06-13 | Pacira Cryotech, Inc. | Pain management using cryogenic remodeling |
US20090248001A1 (en) * | 2007-11-14 | 2009-10-01 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US20090126910A1 (en) * | 2007-11-19 | 2009-05-21 | International Businiess Machines Corporation | Apparatus and method for facilitating servicing of a liquid-cooled electronics rack |
US20090129946A1 (en) * | 2007-11-21 | 2009-05-21 | Arbel Medical, Ltd. | Pumping unit for delivery of liquid medium from a vessel |
US20090222001A1 (en) * | 2007-12-28 | 2009-09-03 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Devices, Methods and Systems |
US8882756B2 (en) | 2007-12-28 | 2014-11-11 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical devices, methods and systems |
US20110015624A1 (en) * | 2008-01-15 | 2011-01-20 | Icecure Medical Ltd. | Cryosurgical instrument insulating system |
US8083733B2 (en) | 2008-04-16 | 2011-12-27 | Icecure Medical Ltd. | Cryosurgical instrument with enhanced heat exchange |
US20090299365A1 (en) * | 2008-05-13 | 2009-12-03 | Medtronic , Inc. | Tissue Lesion Evaluation |
US8821488B2 (en) | 2008-05-13 | 2014-09-02 | Medtronic, Inc. | Tissue lesion evaluation |
US20100081971A1 (en) * | 2008-09-25 | 2010-04-01 | Allison John W | Treatment planning systems and methods for body contouring applications |
US8275442B2 (en) | 2008-09-25 | 2012-09-25 | Zeltiq Aesthetics, Inc. | Treatment planning systems and methods for body contouring applications |
US20100281917A1 (en) * | 2008-11-05 | 2010-11-11 | Alexander Levin | Apparatus and Method for Condensing Contaminants for a Cryogenic System |
US9737434B2 (en) | 2008-12-17 | 2017-08-22 | Zeltiq Aestehtics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
US20100152824A1 (en) * | 2008-12-17 | 2010-06-17 | Allison John W | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
US9066712B2 (en) | 2008-12-22 | 2015-06-30 | Myoscience, Inc. | Integrated cryosurgical system with refrigerant and electrical power source |
US9254168B2 (en) | 2009-02-02 | 2016-02-09 | Medtronic Advanced Energy Llc | Electro-thermotherapy of tissue using penetrating microelectrode array |
US20100198216A1 (en) * | 2009-02-02 | 2010-08-05 | Palanker Daniel V | Electro-thermotherapy of tissue using penetrating microelectrode array |
US7967814B2 (en) | 2009-02-05 | 2011-06-28 | Icecure Medical Ltd. | Cryoprobe with vibrating mechanism |
US8632533B2 (en) | 2009-02-23 | 2014-01-21 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical device |
US20100217255A1 (en) * | 2009-02-23 | 2010-08-26 | Salient Surgical Technologies, Inc. | Fluid-Assisted Electrosurgical Device and Methods of Use Thereof |
US9486283B2 (en) | 2009-02-23 | 2016-11-08 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical device |
US20100234670A1 (en) * | 2009-03-12 | 2010-09-16 | Eyal Shai | Combined cryotherapy and brachytherapy device and method |
US8162812B2 (en) | 2009-03-12 | 2012-04-24 | Icecure Medical Ltd. | Combined cryotherapy and brachytherapy device and method |
US20100241114A1 (en) * | 2009-03-20 | 2010-09-23 | Salvatore Privitera | Cryogenic probe |
US8915908B2 (en) | 2009-03-20 | 2014-12-23 | Atricure, Inc. | Cryogenic probe |
US20100280582A1 (en) * | 2009-04-30 | 2010-11-04 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US11224536B2 (en) | 2009-04-30 | 2022-01-18 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US11452634B2 (en) | 2009-04-30 | 2022-09-27 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US8702774B2 (en) | 2009-04-30 | 2014-04-22 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US9861520B2 (en) | 2009-04-30 | 2018-01-09 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
US20100305439A1 (en) * | 2009-05-27 | 2010-12-02 | Eyal Shai | Device and Method for Three-Dimensional Guidance and Three-Dimensional Monitoring of Cryoablation |
US20110125146A1 (en) * | 2009-09-08 | 2011-05-26 | Salient Surgical Technologies, Inc. | Cartridge Assembly For Electrosurgical Devices, Electrosurgical Unit And Methods Of Use Thereof |
US9345541B2 (en) | 2009-09-08 | 2016-05-24 | Medtronic Advanced Energy Llc | Cartridge assembly for electrosurgical devices, electrosurgical unit and methods of use thereof |
US11751942B2 (en) | 2009-09-08 | 2023-09-12 | Medtronic Advanced Energy Llc | Surgical device |
US20110238050A1 (en) * | 2010-01-25 | 2011-09-29 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods |
US9844461B2 (en) | 2010-01-25 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants |
US9314368B2 (en) | 2010-01-25 | 2016-04-19 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods |
US10085796B2 (en) | 2010-03-11 | 2018-10-02 | Medtronic Advanced Energy Llc | Bipolar electrosurgical cutter with position insensitive return electrode contact |
US9592090B2 (en) | 2010-03-11 | 2017-03-14 | Medtronic Advanced Energy Llc | Bipolar electrosurgical cutter with position insensitive return electrode contact |
US7967815B1 (en) | 2010-03-25 | 2011-06-28 | Icecure Medical Ltd. | Cryosurgical instrument with enhanced heat transfer |
US7938822B1 (en) | 2010-05-12 | 2011-05-10 | Icecure Medical Ltd. | Heating and cooling of cryosurgical instrument using a single cryogen |
US9333027B2 (en) * | 2010-05-28 | 2016-05-10 | Medtronic Advanced Energy Llc | Method of producing an electrosurgical device |
US20140026395A1 (en) * | 2010-05-28 | 2014-01-30 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical devices, and methods of manufacture thereof |
US8080005B1 (en) | 2010-06-10 | 2011-12-20 | Icecure Medical Ltd. | Closed loop cryosurgical pressure and flow regulated system |
US9895191B2 (en) | 2010-06-28 | 2018-02-20 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US9138289B2 (en) | 2010-06-28 | 2015-09-22 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US8906012B2 (en) | 2010-06-30 | 2014-12-09 | Medtronic Advanced Energy Llc | Electrosurgical devices with wire electrode |
US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
US10092346B2 (en) | 2010-07-20 | 2018-10-09 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
US11051880B2 (en) | 2010-11-16 | 2021-07-06 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10045817B2 (en) | 2010-11-16 | 2018-08-14 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US10154878B2 (en) | 2011-09-30 | 2018-12-18 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US8870864B2 (en) | 2011-10-28 | 2014-10-28 | Medtronic Advanced Energy Llc | Single instrument electrosurgery apparatus and its method of use |
US10188444B2 (en) | 2012-01-13 | 2019-01-29 | Myoscience, Inc. | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
US10213244B2 (en) | 2012-01-13 | 2019-02-26 | Myoscience, Inc. | Cryogenic needle with freeze zone regulation |
US9241753B2 (en) | 2012-01-13 | 2016-01-26 | Myoscience, Inc. | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
US11857239B2 (en) | 2012-01-13 | 2024-01-02 | Pacira Cryotech, Inc. | Cryogenic needle with freeze zone regulation |
US9314290B2 (en) | 2012-01-13 | 2016-04-19 | Myoscience, Inc. | Cryogenic needle with freeze zone regulation |
US9155584B2 (en) | 2012-01-13 | 2015-10-13 | Myoscience, Inc. | Cryogenic probe filtration system |
US9017318B2 (en) | 2012-01-20 | 2015-04-28 | Myoscience, Inc. | Cryogenic probe system and method |
US10869717B2 (en) | 2012-10-11 | 2020-12-22 | Tva Medical, Inc. | Devices and methods for fistula formation |
US11707562B2 (en) | 2013-03-14 | 2023-07-25 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
US10821217B2 (en) | 2013-03-14 | 2020-11-03 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US11253393B2 (en) | 2013-03-15 | 2022-02-22 | Pacira Cryotech, Inc. | Methods, systems, and devices for treating neuromas, fibromas, nerve entrapment, and/or pain associated therewith |
US9610112B2 (en) | 2013-03-15 | 2017-04-04 | Myoscience, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
US9668800B2 (en) | 2013-03-15 | 2017-06-06 | Myoscience, Inc. | Methods and systems for treatment of spasticity |
US10085789B2 (en) | 2013-03-15 | 2018-10-02 | Myoscience, Inc. | Methods and systems for treatment of occipital neuralgia |
US11642241B2 (en) | 2013-03-15 | 2023-05-09 | Pacira Cryotech, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
US10016229B2 (en) | 2013-03-15 | 2018-07-10 | Myoscience, Inc. | Methods and systems for treatment of occipital neuralgia |
US10085881B2 (en) | 2013-03-15 | 2018-10-02 | Myoscience, Inc. | Methods, systems, and devices for treating neuromas, fibromas, nerve entrapment, and/or pain associated therewith |
US11134999B2 (en) | 2013-03-15 | 2021-10-05 | Pacira Cryotech, Inc. | Methods and systems for treatment of occipital neuralgia |
US9295512B2 (en) | 2013-03-15 | 2016-03-29 | Myoscience, Inc. | Methods and devices for pain management |
US11865038B2 (en) | 2013-03-15 | 2024-01-09 | Pacira Cryotech, Inc. | Methods, systems, and devices for treating nerve spasticity |
US10596030B2 (en) | 2013-03-15 | 2020-03-24 | Pacira Cryotech, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
US10314739B2 (en) | 2013-03-15 | 2019-06-11 | Myoscience, Inc. | Methods and devices for pain management |
US10888366B2 (en) | 2013-03-15 | 2021-01-12 | Pacira Cryotech, Inc. | Cryogenic blunt dissection methods and devices |
US10667854B2 (en) | 2013-09-24 | 2020-06-02 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter and related methods |
US11179186B2 (en) | 2013-09-24 | 2021-11-23 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter and related methods |
US11883085B2 (en) | 2013-09-24 | 2024-01-30 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter and related methods |
US11241272B2 (en) | 2013-09-30 | 2022-02-08 | Covidien Lp | Bipolar electrosurgical instrument with movable electrode and related systems and methods |
US10631914B2 (en) | 2013-09-30 | 2020-04-28 | Covidien Lp | Bipolar electrosurgical instrument with movable electrode and related systems and methods |
US11690661B2 (en) | 2013-11-05 | 2023-07-04 | Pacira Cryotech, Inc. | Secure cryosurgical treatment system |
US10864033B2 (en) | 2013-11-05 | 2020-12-15 | Pacira Cryotech, Inc. | Secure cryosurgical treatment system |
US10130409B2 (en) | 2013-11-05 | 2018-11-20 | Myoscience, Inc. | Secure cryosurgical treatment system |
US10201380B2 (en) | 2014-01-31 | 2019-02-12 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
US10806500B2 (en) | 2014-01-31 | 2020-10-20 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
US9861421B2 (en) | 2014-01-31 | 2018-01-09 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
US10575890B2 (en) | 2014-01-31 | 2020-03-03 | Zeltiq Aesthetics, Inc. | Treatment systems and methods for affecting glands and other targeted structures |
US10912599B2 (en) | 2014-01-31 | 2021-02-09 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
US11819257B2 (en) | 2014-01-31 | 2023-11-21 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
US11219745B2 (en) | 2014-03-14 | 2022-01-11 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10695534B2 (en) | 2014-03-14 | 2020-06-30 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10675176B1 (en) | 2014-03-19 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Treatment systems, devices, and methods for cooling targeted tissue |
USD777338S1 (en) | 2014-03-20 | 2017-01-24 | Zeltiq Aesthetics, Inc. | Cryotherapy applicator for cooling tissue |
US10617459B2 (en) | 2014-04-17 | 2020-04-14 | Adagio Medical, Inc. | Endovascular near critical fluid based cryoablation catheter having plurality of preformed treatment shapes |
US10952891B1 (en) | 2014-05-13 | 2021-03-23 | Zeltiq Aesthetics, Inc. | Treatment systems with adjustable gap applicators and methods for cooling tissue |
US9974599B2 (en) | 2014-08-15 | 2018-05-22 | Medtronic Ps Medical, Inc. | Multipurpose electrosurgical device |
US10568759B2 (en) | 2014-08-19 | 2020-02-25 | Zeltiq Aesthetics, Inc. | Treatment systems, small volume applicators, and methods for treating submental tissue |
US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
US20160058956A1 (en) * | 2014-08-27 | 2016-03-03 | Tva Medical, Inc. | Cryolipolysis devices and methods therefor |
US10646666B2 (en) * | 2014-08-27 | 2020-05-12 | Tva Medical, Inc. | Cryolipolysis devices and methods therefor |
US9956029B2 (en) | 2014-10-31 | 2018-05-01 | Medtronic Advanced Energy Llc | Telescoping device with saline irrigation line |
US10543032B2 (en) | 2014-11-13 | 2020-01-28 | Adagio Medical, Inc. | Pressure modulated cryoablation system and related methods |
US10603040B1 (en) | 2015-02-09 | 2020-03-31 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US11207070B2 (en) | 2015-02-09 | 2021-12-28 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US11272972B2 (en) | 2015-03-12 | 2022-03-15 | Pacira Cryotech, Inc. | Methods and systems for preventing neuroma formations |
US20160262820A1 (en) * | 2015-03-12 | 2016-09-15 | Myoscience, Inc. | Methods and Systems for Preventing Neuroma Formations |
US10470813B2 (en) * | 2015-03-12 | 2019-11-12 | Pacira Cryotech, Inc. | Methods and systems for preventing neuroma formations |
US11389227B2 (en) | 2015-08-20 | 2022-07-19 | Medtronic Advanced Energy Llc | Electrosurgical device with multivariate control |
US11051875B2 (en) | 2015-08-24 | 2021-07-06 | Medtronic Advanced Energy Llc | Multipurpose electrosurgical device |
US11051867B2 (en) | 2015-09-18 | 2021-07-06 | Adagio Medical, Inc. | Tissue contact verification system |
US11154418B2 (en) | 2015-10-19 | 2021-10-26 | Zeltiq Aesthetics, Inc. | Vascular treatment systems, cooling devices, and methods for cooling vascular structures |
US10864031B2 (en) | 2015-11-30 | 2020-12-15 | Adagio Medical, Inc. | Ablation method for creating elongate continuous lesions enclosing multiple vessel entries |
US10716612B2 (en) | 2015-12-18 | 2020-07-21 | Medtronic Advanced Energy Llc | Electrosurgical device with multiple monopolar electrode assembly |
US10524956B2 (en) | 2016-01-07 | 2020-01-07 | Zeltiq Aesthetics, Inc. | Temperature-dependent adhesion between applicator and skin during cooling of tissue |
US11590322B2 (en) | 2016-01-15 | 2023-02-28 | Tva Medical, Inc. | Devices and methods for advancing a wire |
US10874422B2 (en) | 2016-01-15 | 2020-12-29 | Tva Medical, Inc. | Systems and methods for increasing blood flow |
US11826093B2 (en) | 2016-01-15 | 2023-11-28 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11026743B2 (en) | 2016-01-15 | 2021-06-08 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10765552B2 (en) | 2016-02-18 | 2020-09-08 | Zeltiq Aesthetics, Inc. | Cooling cup applicators with contoured heads and liner assemblies |
US10682297B2 (en) | 2016-05-10 | 2020-06-16 | Zeltiq Aesthetics, Inc. | Liposomes, emulsions, and methods for cryotherapy |
US11382790B2 (en) | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
US10555831B2 (en) | 2016-05-10 | 2020-02-11 | Zeltiq Aesthetics, Inc. | Hydrogel substances and methods of cryotherapy |
US11311327B2 (en) | 2016-05-13 | 2022-04-26 | Pacira Cryotech, Inc. | Methods and systems for locating and treating nerves with cold therapy |
US11285028B2 (en) | 2016-09-25 | 2022-03-29 | Tva Medical, Inc. | Vascular stent devices and methods |
US11076879B2 (en) | 2017-04-26 | 2021-08-03 | Zeltiq Aesthetics, Inc. | Shallow surface cryotherapy applicators and related technology |
US10194975B1 (en) | 2017-07-11 | 2019-02-05 | Medtronic Advanced Energy, Llc | Illuminated and isolated electrosurgical apparatus |
US11672591B2 (en) | 2017-07-11 | 2023-06-13 | Medtronic Advanced Energy Llc | Illuminated and isolated electrosurgical apparatus |
US10806504B2 (en) | 2017-07-11 | 2020-10-20 | Medtronic Advanced Energy, Llc | Illuminated and isolated electrosurgical apparatus |
US11564725B2 (en) | 2017-09-05 | 2023-01-31 | Adagio Medical, Inc. | Ablation catheter having a shape memory stylet |
US11134998B2 (en) | 2017-11-15 | 2021-10-05 | Pacira Cryotech, Inc. | Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods |
US11751930B2 (en) | 2018-01-10 | 2023-09-12 | Adagio Medical, Inc. | Cryoablation element with conductive liner |
US11446175B2 (en) | 2018-07-31 | 2022-09-20 | Zeltiq Aesthetics, Inc. | Methods, devices, and systems for improving skin characteristics |
US11633224B2 (en) | 2020-02-10 | 2023-04-25 | Icecure Medical Ltd. | Cryogen pump |
CN113576648A (en) * | 2021-06-30 | 2021-11-02 | 海杰亚(北京)医疗器械有限公司 | Ablation device |
US11540868B1 (en) | 2021-06-30 | 2023-01-03 | Hygea Medical Technology Co., Ltd. | Ablation device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4802475A (en) | Methods and apparatus of applying intra-lesional cryotherapy | |
US6503246B1 (en) | Cryoprobe and method of treating scars | |
CN107635474B (en) | Methods and systems for manipulating ovarian tissue | |
JP6596436B2 (en) | Methods and systems for the treatment of polycystic ovary syndrome | |
AU671405B2 (en) | Medical probe device | |
US6772766B2 (en) | Cryogenic method and apparatus for promoting angiogenesis | |
Weshahy | Intralesional cryosurgery a new technique using cryoneedles | |
Torre | Continuing medical education (Dermatologic surgery): Cryosurgery of basal cell carcinoma | |
US11844559B2 (en) | Surgical method and apparatus for destruction and removal of intraperitoneal, visceral, and subcutaneous fat | |
Ramadhyani | Cryoablation for the treatment of solid cancers and pain management | |
US20190029745A1 (en) | Systems and methods to treat wounds | |
WO1998044857A1 (en) | Method and system for performing trans-rectal radiofrequency urethral enlargement | |
EP3060149B1 (en) | Trocar with a freezing probe | |
US9241754B2 (en) | Nerve and soft tissue ablation device | |
Ahmed et al. | History of cryosurgery | |
Wyse et al. | Percutaneous thermal ablation in the head and neck: current role and future applications | |
Mesquita Filho et al. | Cryotherapy for Cosmetic Procedures | |
Harvey | Cryosurgery for prostate cancer | |
Roenigk et al. | Cryosurgery/Emanuel G. Kuflik | |
Bhatia et al. | Operative procedures | |
Prohaska et al. | Cryotherapy in Dermatology | |
Szkodziak | Cryotherapy in gynecology in the light of current scientific reports | |
Montmayeur et al. | The development of cryosurgical instruments for internal medicine | |
Marini | Cryosurgery | |
Kuflik | MECHANISMS OF INJURY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 19970212 |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |